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Genome variation over multiple timescales and dimensions 
Kathleen Keough 
Abstract 
Genomic variation does not only include nucleotide changes, it also comprises changes 
in DNA shape, structure, epigenetic marks, and expression, all of which can occur over 
generations, cellular differentiation, the span of a few hours or a few millennia.  This 
doctoral thesis explores the implications and opportunities presented by these multiple 
forms of genomic variation for genome editing, cellular differentiation, genome 
regulation and comparative genomics, all towards improving our understanding of 
genome evolution and development and benefiting human health. 
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1 Introduction  
 
Genomic variation exists on all scales from DNA sequence to genome structure. 
Variations between individual genomes render us unique, while also rendering us 
susceptible to disease. Inter-individual variation is not always random, it is often 
inherited, passed from parent to child, generating networks of genomic variation tracing 
us back to the first humans (Sudmant et al., 2015). These patterns of shared genomic 
variation can then be used to assign us to groups, either at a high level with clades and 
species, within a species such a population groups, or at an even finer resolution, 
linking us to previously unknown family members. We can also be grouped genetically 
based on our susceptibility to various diseases. However, in this work I use shared 
genetic variation as a tool, using those same networks of genetic sharedness to design 
genomic tools specific to individuals with a particular disease that aim to amend the 
cause of the disease at its genetic source (Keough et al., 2019).  
 
On a longer timescale, genomic variation, or the lack thereof, reminds us how very 
similar we actually are to the other species that share this planet with us. Many of our 
basic physiological processes, breathing, pumping blood, digestion, are common 
throughout mammals and further, and this similarity is reflected throughout our 
genomes. Most of our genome is exactly the same as our closest living relative, the 
chimpanzee, and yet there are clearly many differences between our species. The 
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genetic cause of these differences likely lies in the 98% of our genomes that are 
noncoding. This was shown in a seminal paper that compared the similarity between 
human and chimpanzee for the sequences that code for genes , finding that they are 
highly identical, suggesting that noncoding sequences have a major impact for 
differences between organisms (King and Wilson, 1975). To try and understand these 
differences subtly encoded in our genomes, we hone in on the fastest evolving loci 
known in humans (Pollard et al., 2006a, 2006b). To these loci we add further 
dimensions of information, made possible by technological advances since their 
discovery such as high-throughput sequencing, new methods for computational analysis 
of genomes, and techniques to disentangle the meaningful organization of the genome 
in 3D at a high resolution. These new data around these intriguing loci enable us to 
develop and pursue new hypotheses for their origin and function, and get closer to 
determining what makes us human.  
 
Despite our complexities as humans, we are still susceptible to some of the most basic 
pathogens: RNA viruses, fast-evolving predators waging war against the entire 
phylogenetic tree of life. As I wrote this thesis, SARS-CoV2 brought the world to a halt 
(Zhou et al., 2020). This insidious foe was able to pass between species and 
individuals, often without symptoms, frequently deadly, without a cure or treatment. 
Scientists around the world dropped everything to help where they could, and I joined 
them to identify how our genomic similarities and variation may render some species 
more or less vulnerable to this virus, to enable more informed conservation efforts, 
potentially inform model animal selection, essential for vaccine and treatment 
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development, and inform other sources of risk, such as agriculture (Damas et al., 2020). 
That work continues beyond what is included here. 
 
Finally, variation in genomic structure is important for health and development. I explore 
some of the basic foundations of this via analysis of lamina-associated and H3K9me2-
associated domains. These generally repressive, heterochromatic regions comprise a 
huge portion of our genomes, and yet our understanding of how they’re generated, what 
is their function, and how they interact with other genomic elements is nascent (Guelen 
et al., 2008; Meuleman et al., 2013; Peric-Hupkes et al., 2010; Poleshko et al., 2017). 
Disruption of these elements disrupts differentiation and causes disease, and so a 
better understanding is necessary. By applying a previously unused type of statistical 
model to the data, I uncover evidence that these regions are not monolithic, but 
comprise multiple subtypes, each of which vary between different cell types and encode 
cell-type-specific information.  
 
Genomic variation defines us; it is both our boon and our bane, generating both 
beneficial traits and disease. The advances in this doctoral thesis contribute to our 
understanding of the forces of genomic variation in sequence and shape over cellular 
differentiation and evolutionary time, within and between individuals and species, and 
provides a tool to use genomic variation against genomic variation-based disease.   
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2 AlleleAnalyzer: a tool for personalized and allele-specific gRNA 
design 
 
The work described in this chapter was previously published in Genome Biology 
(Keough et al., 2019). The end result of this study was a more thorough understanding 
of the implications and opportunities presented by naturally occurring genomic variation 
(single nucleotide variants and small insertions or deletions) in the field of CRISPR 
genome editing guide RNA (gRNA) design, as well as an open-source software tool 
(https://github.com/keoughkath/AlleleAnalyzer) to design and optimize gRNA 
combinations based on genetic variation to maximize coverage of a cohort.  
 
2.1 Rationale for considering genomic variation in CRISPR gRNA design  
 
CRISPR genome editing success depends on the efficiency and specificity of the gRNA 
design. Current gRNA design tools primarily predict efficiency and specificity of gRNAs 
using features such as prevalence of off-target sites, epigenetic marks and chromatin 
accessibility (Doench et al., 2014; Haeussler et al., 2016; Horlbeck et al., 2016). 
Generally, gRNAs are designed using reference genomes, such as the hg38 assembly 
for human or the GRCm38 assembly for mouse. However, these gRNAs are used on 
cell lines or organisms with many nucleotide differences from the reference (e.g., on 
average 0.1% of a human genome (National Institutes of Health, 2007)). While gRNAs 
can sometimes tolerate a single base-pair mismatch, frequently these mismatches 
negatively impact gRNA efficiency and render imprecise the results of specificity 
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prediction (Scott and Zhang, 2017; Yang et al., 2014), with potentially serious effects 
when gRNAs are deployed.  
 
Previous work analyzing data from Exome Aggregation Consortium (ExAc) (Lek et al., 
2016) and the 1000 Genomes project (1000 Genomes Project Consortium et al., 2015) 
determined that genetic variants could have a large impact on gRNA efficiency and 
specificity, demonstrating the need for a tool to design gRNAs using genetic variation 
and to identify gRNAs that could work in many people to facilitate regulatory approval 
for therapeutic use . The solution implemented in this previous work was to avoid 
negative effects of genetic variation by identifying universal gRNAs located in sites with 
little to no genetic variation and possessing few predicted off-targets (Scott and Zhang, 
2017). However, many loci that may need to be edited lack variation-free regions for 
designing such gRNAs (see below). We propose personalized gRNA design, which 
uses the genetic variants in a genome or population, as a second approach that offers 
more flexibility in guide design. We further note that genetic variation is not only a 
challenge for gRNA design, but also an opportunity. Specifically, the use of CRISPR in 
research areas such as haploinsufficiency, genomic imprinting, and dominant negative 
diseases requires allele-specific gRNA design, which may be accomplished using 
heterozygous variants.  
 
To address these needs, I developed AlleleAnalyzer, an open-source Python software 
tool that designs personalized and allele-specific gRNAs for individual genomes, 
identifies pairs of gRNAs to generate excisions likely to block expression of a gene, and 
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leverages patterns of shared genetic variation across thousands of publicly available 
genomes to design gRNA pairs that will have the greatest utility in a target population. 
 
2.2 Incorporating genomic variation into gRNA design 
Incorporating genetic variation into gRNA design enables personalized and allele-
specific CRISPR experiments. A personalized gRNA is defined here as an gRNA 
designed to incorporate the genetic variants of the research subject. A genetic variant 
can impact gRNA sites by being located in or near a protospacer adjacent motif (PAM 
site), potentially generating or eliminating gRNA sites in an individual in a heterozygous 
or homozygous manner. Beyond being an impediment to designing effective gRNAs, 
these variants enable the design of personalized, non-allele-specific gRNAs 
(incorporating homozygous variants and avoiding heterozygous variants to match both 
alleles) and allele-specific gRNAs (incorporating heterozygous variants). The way in 
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which genetic variation impacts or is incorporated into gRNA design depends on the use 
case for the gRNA and variant zygosity (Figure 1a).  
 
Because Cas nucleases have different PAM sequences, a variant may impact an gRNA 
site for one Cas but not another. We analyzed 11 Cas types (Error! Reference source 
not found.),  
Figure 1:  Analysis of allele specific gRNA sites 
A) In a sample genome, tools designing gRNAs for the reference genome are imperfect 
matches due to genetic variants, exemplified by guide 1. AlleleAnalyzer designs personalized 
gRNAs, as demonstrated by guides 2 and 3, which incorporate homozygous and avoid 
heterozygous variants, thus designing a guide perfectly matched to both alleles in a subject. It 
also designs personalized allele-specific gRNAs based on incorporation of heterozygous 
variants, shown by guides 4-6. Guides 4 and 6 target the paternal allele, while guide 5 targets 
the maternal allele. B) Most variants annotated by the 1000 Genomes Project (1KGP) and the 
Exome Aggregation Consortium (ExAc) are in or near a PAM site. C) Analysis of common 
variants (minor allele frequency (MAF) greater than 5% in 1KGP), and all variants in an 
individual cell line (WTC) within commonly used gRNA libraries.  
 
a.
b.
ATCGAATCTGCCTGAGCCAACGG
CCAATCTGCCTGAGCCAACGGAT
ATCCAATCTGCCTGAGCCAACGG
CCAACGGATCTAGCTAGGCTGAA
CCAACGGATCTAGCTAGCCTGAA
ATCCAATCTGCCTGAGCCAACGGATCTAGCTAGCCTGAATCG
ATCCAATCTGCCTGAGCCAACGGATCTAGCTAGGCTGAATCG
ATCGAATCTGCCTGAGCCAACGGATCTAGCTAGCCTGAATCG
CTGAGCCAACGGATCTAGCTAGG
Reference sequence
Research subject, maternal allele
Research subject, paternal allele
Guide 1
Guide 2
Guide 3
Guide 4
Guide 5
Guide 6
Reference sgRNA
Personalized sgRNA
Allele-specific sgRNA
Genetic variant in research subject
PAM
PAM
PAM
c.
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Common 
name(s) 
Abbreviation PAM Properties 
SpCas9 SpCas9 NGG Streptococcus pyogenes (Sp) Cas9., most 
widely used version with dozens of variants 
using same PAM, e.g. eSpCas9, SpCas9-
HF1, eSpCas9 1.1 and more (Jinek et al. 
2012) 
SpCas9 
VRER 
Variant 
SpCas9-V1 NGCG Version of  SpCas9 with alternative targeting 
range (Kleinstiver et al. 2015) 
SpCas9 
EQR 
Variant 
SpCas9-V2 NGAG Version of  SpCas9 with alternative targeting 
range (Kleinstiver et al. 2015) 
SpCas9 
VQR 
Variant 
SpCas9-V3 NGAN or 
NGNG 
Version of  SpCas9 with wider targeting 
range (Kleinstiver et al. 2015) 
SaCas9 SaCas9 NNGRRT Staphylococcus aureus (Sa) Cas9.  Small 
relative to SpCas9, (Horvath et al. 2008, 
Jiang et al. 2013) 
SaCas9 
KKH 
Variant 
SaCas9-V1 NNNRRT Version of  SaCas9 with 2 to 4-fold 
increased targeting range relative of SaCas9 
(Kleinstiver et al. 2015) 
nmCas9 nmCas9 NNNNGATT Neisseria meningitidis (Nm) Cas9, with 
different PAM site (Hou et al. 2013) 
cpf1 cpf1 TTTN Multiple variations, notably opposite 
orientation system and sticky-end cut rather 
than blunt. Multiple species exist, including 
from Acidaminucoccus and 
Lachnospiraceae. (Zetsche et al. 2015) 
StCas9 1 StCas9-V1 NNAGAA Streptococcus thermophilus (St) Cas9. 
Smaller relative of SpCas9. Increased 
specificity. (Kleinstiver et al. 2015, Muller et 
al. 2016) 
StCas9 2  StCas9-V2 NGGNG Streptococcus thermophilus (St) Cas9. 
Smaller relative of SpCas9. Increased 
specificity. (Muller et al 2016) 
cjCas9 cjCas9 NNNNACA Campylobacter jejuni Cas9. Smallest Cas9 
ortholog to date, easy to package (Kim et al. 
2017) 
Table 1: Cas types 
11 types of Cas enzyme were evaluated, each of which has a distinct PAM site. 
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genome-wide variants from >2500 individuals from the 1000 Genomes Project(1000 
Genomes Project Consortium et al., 2015) (1KGP), and exome variants from >60,000 
individuals in ExAc. From these analyses we discovered that most variants impact 
gRNA sites for at least one Cas type, even when considering only variants in PAMs, 
which are putatively more  allele-specific (Christie et al., 2017) (Figure 1b). The 
likelihood that a variant impacts an gRNA site differs across Cas nucleases (1KGP: 
range 19-98%, ExAc: range 13-99%), is positively correlated with PAM frequency in the 
reference genome (1KGP: Pearson rho=0.89, p=0.0002, ExAc: Pearson rho=0.84, 
p=0.0011, Figure 4a), and is negatively correlated with PAM size (1KGP: Pearson rho=-
0.71, p=0.014, ExAc: Pearson rho=-0.74, 
p=0.0094). In fact, >3% of gRNAs in each of 
three widely used gRNA libraries (Doench et 
al., 2016; Morgens et al., 2017; Park et al., 
2016) contain at least one common genetic 
variant (minor allele frequency > 5% in the 
1KGP cohort), and >2% of these gRNAs 
contain a variant in the individual human 
genome of an induced pluripotent stem cell 
(iPSC) line WTC, commonly used for disease 
modeling (Drubin and Hyman, 2017) (Figure 
1c, Figure 2). Failing to account for variants can reduce the efficacy of gRNAs and also 
Figure 2: gRNA variants in WTC iPSC 
Genomic variants in commonly-used 
gRNAs libraries in the WTC iPSC line. 
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generate unexpected off-target effects (Lessard et al., 2017). These results emphasize 
the importance of designing gRNAs using the personal genome of the patient or cell line 
where they will be deployed, or at least accounting for both heterozygous and 
homozygous genetic variants when interpreting results using gRNA libraries designed 
for the reference genome. 
 
Heterozygous genetic variants can be leveraged to establish new therapeutic and 
research possibilities with allele-specific genome editing. Questions that allele-specific 
editing could help address include haploinsufficiency, imprinting, and allele-specific 
gene regulation, as well as discovery and correction of heterozygous disease variants. 
One promising example is genome surgery to treat dominant negative disease by 
excising only the disease causing copy of a gene, an approach which rescues healthy 
phenotypes in cell and animal models of dominant negative diseases including 
Huntington’s disease (Shin et al., 2016a) and retinitis pigmentosa (Bakondi et al., 2015; 
Gao et al., 2018).   
The strategy of allele-specific gene editing genome-wide was assessed by identifying 
pairs of allele-specific gRNA sites for each human protein-coding gene that could 
generate a genomic excision and eliminate protein production from just one allele. 
Given a Cas nuclease, an estimated maximum distance between the two gRNAs on the 
haplotype to be excised, and allele-specific gRNA sites based on the individual’s 
genetic variants, it is possible to classify genes–or other genomic elements such as 
enhancers–as putatively targetable or not (Figure 3). 
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Figure 3: Allele-specific gene targeting with paired gRNAs 
Strategy to determine whether a gene is targetable for dual-gRNA allele-specific 
excision-based knockout. 
 
The term putatively targetable is used here when a pair of allele-specific gRNAs exists 
but has not yet been tested, because it will not always be possible to cut specifically at a 
Noncoding exon
Coding exon
Allele-specific cut site
✔
✔
✔
✘
Maternal
Maternal 
Maternal 
Maternal 
Paternal 
Paternal 
Paternal 
Paternal 
✔
✘
Putatively
targetable
Not targetable
 12 
site and coding exon excision will not always stop expression. Previous work indicates 
that excision of large genomic fragments (>10 kilobases) is feasible, and that excision of 
coding exons via gRNAs targeted to flanking noncoding regions, such as promoter or 
intronic regions, can mediate gene knockout (Chen et al., 2014; Shin et al., 2016b; 
Tabebordbar et al., 2016).  
 
 
Figure 4: Target availability by Cas enzyme 
A) PAM frequencies in the human reference genome hg19, colored by size of the PAM site 
(number of non-“N” nucleotides in motif). B) In this faceted density plot, height of the colored 
portion indicates the proportion of genes where the specified percentage (on the x-axis) of the 
1000 genomes cohort is putatively targetable. 
 
As an example, suppose we choose a maximum distance of 10 kilobases (kb) between 
gRNAs, require the gRNAs to be within the gene including introns, and consider 11 Cas 
varieties (Table 1). Then the average individual from 1KGP is putatively targetable for 
allele-specific excision at 64% of protein-coding genes (Shin et al., 2016a). The rate of 
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putatively targetable individuals per gene is evenly distributed across chromosomes but 
varies by Cas nuclease and gene (Figure 4b). For genes that are not putatively 
targetable, additional allele-specific gRNA sites may be found by leveraging non-coding 
variants up- and down-stream of the gene, or even in distal enhancers for the gene 
(Shin et al., 2016a). As a second example, I found that by simply including the 5 kb 
flanking regions of each gene, we can increase the mean proportion of putatively 
targetable protein-coding genes per 1KGP individual to 75%. A caveat to this is that 
specificity of each gRNA pair will vary greatly, potentially even between gRNAs 
targeting the same pair of heterozygous variants. Therefore, we conclude that allele-
specific excision may be applicable to the vast majority of genes in most human 
genomes, but extensive experimental optimization for efficiency and specificity will be 
needed.  
 
Since some genes in a given individual do not 
have a pair of allele-specific gRNAs, we asked 
if gene silencing with a single allele-specific 
gRNA within the coding sequence (single-
guide strategy) makes more genes putatively 
targetable. I compared paired-guide and 
single-guide strategies for allele-specific gene 
knockout in the individual human genome of 
the WTC iPSC line (Drubin and Hyman, 2017) 
and found that more than twice as many  
Figure 5: Genes targetable in WTC with 
single- or paired-gRNA approach 
Genes were evaluated using variants 
from the WTC iPSC line for targetability 
based on a single- or paired-gRNA 
approach. 
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genes are 
putatively 
targetable with 
paired guides 
despite the 
requirement of 
two editing sites 
(Figure 5). This 
follows intuition, 
because one or 
both gRNAs can 
fall in introns or 
untranslated 
regions 
(providing more 
potential editing 
sites with dual 
guides), whereas 
individual gRNAs 
in the single-guide 
strategy are 
limited to coding 
regions. Genes that are putatively targetable with a single- and not paired-guide 
Input: 
- Genetic variant information for the cohort
- Maximum number of sgRNA pairs desired, x
- sgRNA pairs available
- Putative targetability 
information for available 
sgRNA pairs
} Generated byAlleleAnalyzer
Example: Choose the best pair of 
genetic variants (allele-specific sgRNA sites)
that putatively target a theoretical 
gene to cover a given cohort. For simplicity, 
sgRNA sites are referred to as sgRNAs, 
however in practice each is a genetic variant
from which multiple allele-specific sgRNAs
may be designed.
x = 1 (Maximum number of sgRNA pairs)
sgRNA-1 sgRNA-3 sgRNA-5
sgRNA-2 sgRNA-4 sgRNA-6
Genetic variant with location on 
sgRNA for the reference (ref ) allele
sgRNA for the alternate (alt) allele
Exon
10135 10587 10691
chr pos ref   alt   ind1   ind2   ind3
chr1
chr1
chr1
10135
10587
10691
A
C
C
G
T
G
G|G
T|C
G|C
G|A
T|CC|T
C|G C|G
A|A
Bipartitate graph of targetability of each individual 
for each sgRNA pair based on personal genotypes
sgRNA-1 (ref )
sgRNA-1 (ref ) ind 1
ind 2
ind 3
sgRNA-1 (ref )
sgRNA-1 (ref )
sgRNA-2 (ref )
sgRNA-2 (ref )
sgRNA-3 (ref )
sgRNA-3 (ref )
sgRNA-4 (ref )
sgRNA-4 (ref )
sgRNA-2 (ref )
sgRNA-2 (ref )
sgRNA-3 (ref )
sgRNA-4 (ref )
sgRNA-5 (ref )
sgRNA-6 (ref )
sgRNA-5 (ref )
sgRNA-6 (ref )
sgRNA-5 (ref )
sgRNA-6 (ref )
sgRNA-5 (ref )
sgRNA-6 (ref )
sgRNA-4 (ref )
sgRNA-3 (ref )
sgRNA pair Individual 0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
i = j =
Σj=3
Σi=1
Indicator variables 
sgRNA pair 12
Number of 
individuals covered:
Number of 
sgRNA pairs used:
For each sgRNA pair, generate indicator variable vectors for 
individuals covered (i) and sgRNA pairs used (j). Σj must 
be less than the limit (x) specified by the user.  
Therefore, sgRNA
pair 12 is an optimal
solution for this case.
chromosome
Figure 6: Set cover approach to maximize population coverage by 
variant-informed gRNA selection 
Our approach, based on the set cover problem, to maximize 
coverage of a population group based on informed variant 
selection for gRNA design. 
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approach tend to have less than two heterozygous variants in the gene, indicating that a 
lack of multiple variants is the primary reason a paired-guide strategy fails. These genes 
could be putatively targetable with a paired-guide strategy by incorporating flanking, 
promoter, or other regulatory regions. Again, putative editing sites and gRNAs need to 
be experimentally validated. This suggests that in most cases allele-specific gene 
targeting may be greatly enhanced by including paired-guides in the experimental 
approach. 
 
Genome editing gRNAs do not need to be designed one genome at a time. Variants 
that impact gRNA sites are often shared among large proportions of the individuals 
within and sometimes between populations due to haplotype structure. Previous work 
had a similar goal of developing gRNAs for broad use (Scott and Zhang, 2017). 
However that work focused on targeting invariant (or low variation) segments of the 
genome towards homozygous, single-gRNA-based CRISPR editing while  
AlleleAnalyzer focuses on taking advantage of genome variation for allele-specific 
editing with individual gRNAs, or pairs of gRNAs. Allele sharing varies by population 
and locus, as individuals with common ancestry will share haplotypes that harbor 
specific sets of variants. We therefore developed an algorithm to identify allele-specific 
gRNA guide pairs for a given gene that cover the maximum number of individuals in a 
population; these have the broadest therapeutic potential, similar to designing a drug to 
treat as many people as possible (Error! Reference source not found.). Specifically, 
this method seeks to cover the most people with the fewest gRNA pairs using their 
shared heterozygous variants; this is similar to the “set cover” problem in that the 
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algorithm identifies an optimal combination rather than simply selecting most shared 
gRNA pairs, which could disproportionately favor one group over another (Clarkson, 
1993). Our algorithm generates optimized pairs of gRNAs that can be used to study or 
treat genetic diseases in large groups, potentially eliminating the need to develop new 
gRNA pairs for each patient or cell line, with practical implications for the development 
of genome surgery as a field. Our algorithm can also be used to identify gRNA pair 
Figure 7: Targeting pairs of allele specific polymorphisms 
A) Common shared targetable variant pairs for SpCas9 and SaCas9 vary greatly by 
population, as demonstrated in the gene BEST1 including the 5kb flanking regions in the five 
1000 Genomes superpopulations. B) AlleleAnalyzer optimizes gRNA pair combinations to 
best cover a cohort, which performs much better compared to the naïve approach of 
selecting the most highly shared pairs (“Top 5”). C) The pairs identified by the AlleleAnalyzer 
and Top 5 approaches demonstrate disparate patterns of sharing among the entire 1KGP 
population. Height of the arcs is only for visualization purposes, and is not otherwise 
meaningful. D) AlleleAnalyzer designs gRNAs, colored by Cas variety, here with SpCas9 
represented by purple and SaCas9 by green. E) For each variant, or gRNA site, multiple 
gRNAs can be designed on both the reference and alternate alleles, depending which is to 
be targeted. Each gRNA, then, has its own set of off-target sites, predicted using the 
incorporation of the CRISPOR tool in AlleleAnalyzer.  
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combinations applicable to a custom cohort; this enables researchers to design guides 
that are maximally shared among multiple cell lines, for example, which would improve 
experimental efficiency. Optimized gRNAs can then be validated for each individual via 
targeted genotyping, reducing sequencing and gRNA synthesis costs.  
 
As a case study, I investigated the feasibility of excising at least one coding exon of 
bestrophin 1 (BEST1), which can cause dominant negative macular degeneration (Yang 
et al., 2015). Because mutations in this gene can cause macular degeneration by a 
dominant negative mechanism, a strategy that eliminates or silences the disease allele 
would be therapeutically desirable. Considering the gene plus 5 kb of flanking sequence 
on either side, and allowing 10 kb between each gRNA in a pair, there are 563 pairs of 
allele-specific gRNA sites for SpCas9 that are shared by >10% of all 1KGP individuals, 
with the number and composition of these pairs varying across 1KGP populations 
(Figure 3a). The goal was to identify an optimal combination of five allele-specific gRNA 
pairs to potentially target the majority of the 1KGP cohort. The result was that a 
combination of five allele-specific gRNA pairs could putatively excise at least one coding 
allele of BEST1 while leaving the other allele intact in ~78% of the overall 1KGP 
population. This compares to only 48% that would be covered by the naïve approach of 
selecting a combination of the top 5 most highly shared pairs (Figure 3b, c). At each 
gRNA site, multiple gRNAs are possible for both the reference and alternate alleles 
(Figure 3d) depending on which is being targeted in the research subject. Each of these 
gRNAs has a unique off-target profile (Figure 3e), which we identified by integrating the 
tool CRISPOR into AlleleAnalyzer (Haeussler et al., 2016). Previous studies have 
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predicted that genetic variation may have a large impact on the off-target landscape 
(Lessard et al., 2017; Scott and Zhang, 2017). One of these produced a set of 
“platinum” gRNAs for all coding genes identified based on the target sites having low 
genetic variation and predicted off-targets, including off-targets generated by genetic 
variation (Scott and Zhang, 2017). Using the WTC genome, I compared these gRNAs to 
those produced by AlleleAnalyzer in the gene proprotein convertase subtilisin/kexin type 
9 (PCSK9), a gene involved in various cardiovascular diseases and susceptibility to HIV 
infection (Dixon et al., 2016). 
 
Figure 8: Comparison of gRNAs from AlleleAnalyzer to platinum gRNAs at PCSK9 
Demonstration of the ability of AlleleAnalyzer to design gRNAs where other tools cannot due to 
incapability to incorporate genetic variants.  
 
A.
B.
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I determined that the set of platinum gRNAs indeed has high predicted sensitivity and 
specificity in WTC, but some loci lack platinum gRNAs; AlleleAnalyzer is able to design 
personalized gRNAs in these loci, making it a flexible option that we expect will be 
Figure 9: gRNA pair optimization for coverage of groups 
A.) Variant pairs in NEFL and the flanking 5kb that are shared by at least 10% of the 
1KGP cohort. These are pairs of variants, not pairs of gRNAs, so reflect potential dual-
guide editing sites prior to designing or filtering gRNAs. 10% was chosen for 
visualization purposes. B.) 5 variant pairs identified by AlleleAnalyzer to achieve 
greatest possible coverage of the 1KGP cohort. C.) Coverage of the 1KGP cohort with 
the AlleleAnalyzer set of 5 pairs at various minimum predicted specificity score 
thresholds. D.) Coverage of each super population in the 1KGP cohort with the 
AlleleAnalyzer set of 5 pairs at various minimum predicted specificity score thresholds. 
E.) 5 top shared variant pairs in the 1KGP cohort. F.) Coverage of the 1KGP cohort with 
the “Top 5” set of pairs at various minimum predicted specificity score thresholds. G.) 
Coverage of each super population in the 1KGP cohort with the “Top 5” set of pairs at 
various minimum predicted specificity score thresholds. 
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useful in practice (Figure 8). CRISPOR specificity scoring will be robust to most 
variation as it searches for all similar sites in the genome to an gRNA with up to four 
mismatches. Additionally, the predictive power of these scores is low in general 
(Haeussler et al., 2016).  
 
AlleleAnalyzer allows the user to filter gRNAs for predicted specificity, and doing so can 
impact relative coverage using either the AlleleAnalyzer or top 5 pairs methods, as 
demonstrated here in six therapeutically relevant genes including neurofilament light 
gene (NEFL) (Error! Reference source not found.), a gene in which dominant 
negative mutations can cause Charcot-Marie-Tooth disease (Miltenberger-Miltenyi et 
al., 2007). Therefore, particularly in cases of therapeutic development, we recommend 
rigorous experimental whole-genome off-target analysis. Together, these results 
demonstrate important considerations for allele-specific gRNA design. 
 
2.3 Open-source software tool for genetic-variation-aware gRNA design 
The bioinformatics methods from this study have been implemented in AlleleAnalyzer, 
an open-source Python software tool (Error! Reference source not found.). This tool 
designs personalized and allele-specific gRNAs for unique individuals and cohorts, 
given their genetic variants, and optimizes gRNA pairs to cover many individuals based 
on shared variants. To our knowledge, this is the first computational resource that 
designs personalized and allele-specific CRISPR gRNAs. AlleleAnalyzer accounts for 
single nucleotide variants and short insertions and deletions, and currently supports 
eleven Cas proteins while  
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providing user options to add new Cas proteins, thus expanding and building upon the 
existing repertoire of gRNA design tools. The AlleleAnalyzer toolkit and tutorials are 
available along with the database of annotated 1KGP variants at:  
https://github.com/keoughkath/AlleleAnalyzer under the MIT license (DOI: 
10.5281/zenodo.3354488) 
 
 
Figure 10: AlleleAnalyzer tool overview 
Overview of designing gRNAs with AlleleAnalyzer. 
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2.4 Methods 
PAM occurrence in the human reference genome 
PAM frequency 
The AlleleAnalyzer tool includes a script enabling scanning of a reference genome fasta 
file for existing PAM sites. This was used to identify PAM sites for 11 Cas types (Figure 
4, Error! Reference source not found.) in the reference human genomes hg19 and 
hg38. These are viewable in publically accessible UCSC Genome Browser sessions 
(hg19: https://bit.ly/2GB9cXK, hg38: https://bit.ly/2BZAmVh). 
 
PAM size 
PAM sizes were equated as the sum of non-N (A, C, G or T) bases in a PAM site. Thus 
“NGG” for SpCas9 would have size 2, and “NNGRRT” for SaCas9 would have size 4. 
 
Analysis of variants in commonly used gRNA libraries 
For each gRNA library, genomic coordinates for the protospacer regions were obtained 
from the relevant supporting manuscript. These were converted into BED files including 
the protospacer and PAM sites. Bcftools(Danecek et al., 2014) then was used to extract 
variants with a minor allele frequency (MAF) > 5% from the 1000 Genomes data, or 
variants from WTC with no MAF restriction. Variants that fell in the “N” position of the 
PAM were removed.  
AlleleAnalyzer analyses 
Annotation of variants 
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Genetic variants were determined to generate or destroy an allele-specific gRNA site if 
they were proximal to or in a PAM site (Figure 1a). Sufficient proximity to a PAM site 
was defined for this study as 20 base pairs based on the common length of gRNA 
recognition sequences. For all Cas varieties this was the 20 base pairs 5’ of the PAM, 
except for cpf1 (Cas12a) for which it was 3’ of the PAM. The gRNA design tools that are 
part of AlleleAnalyzer allow different user-defined gRNA lengths and addition of Cas 
enzymes and PAMs. There is evidence to suggest that genetic variants that generate or 
destroy a PAM are more likely to lead to allele-specific Cas activity compared to those 
in the seed sequence (Doench et al., 2014); AlleleAnalyzer thus provides options to 
differentiate between CRISPR sites in a PAM site versus the gRNA recognition 
sequence. All variants genome-wide were annotated for the 1KGP cohort for reference 
genomes hg19 and hg38. All variants in the ExAc dataset were annotated for the 
reference genome hg19 only, as that dataset is not available in hg38. 
 
Generation of gene set 
 
The analyzed gene set was compiled using the canonical transcripts for RefSeq gene 
annotations for human reference genome hg19 and hg38 downloaded using the UCSC 
table browser(Karolchik et al., 2004). Values reported in the text are for hg19 unless 
stated otherwise, but 1KGP analyses were conducted for both reference genomes with 
similar results. 
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Allele-specific putative gene targetability genome-wide 
 
Putative allele-specific targetability of a gene is defined here as whether a gene 
contains a pair of allele-specific gRNA sites for at least one of the 11 Cas enzymes 
evaluated that are less than 10 kb apart on the same haplotype in an individual that will 
disrupt a coding exon (Figure 3). This metric was calculated for each gene for all 2,504 
1KGP individuals. It was not calculated for the ExAc cohort as that dataset contains only 
exome rather than whole-genome variants. 
 
Set cover analysis 
 
In order to find the optimal set of gRNAs, two vectors of indicator variables were 
initialized that are constrained to be binary, one for gRNAs and one for individuals. 
When these indicator variables are set to 1, this means a gRNA is chosen or a person is 
covered, respectively. The objective function was specified to maximize the sum of 
person indicator variables. Next, the constraint was set on maximum value allowed for 
the sum of gRNA indicator variables. Finally, the constraints deduced from the data 
were assembled into the bipartite graph of gRNAs and patients targetable by them. This 
graph gets translated to multiple inequality constraints that specify that if a person 
indicator is 1, then at least one of its connected gRNA indicators must also be 1. Having 
specified all these elements of the problem, one may solve it with any number of integer 
linear programming solvers; here the Python package PuLP was used (Mitchell et al., 
2011). The final values of the indicator variables were extracted from the solution with 
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the set of gRNAs that fulfill the chosen objective. The specific python implementation of 
the constraints and objective function and subsequent call to an integer linear 
programming solver can be seen in the GitHub repository for this tool. This is visualized 
in Figure 3. 
 
Comparison of AlleleAnalyzer to platinum gRNAs from Scott & Zhang 2017 
 
Platinum gRNAs for SpCas9 were obtained from the supplementary materials of their 
paper (Scott and Zhang, 2017). Personalized non-allele-specific gRNAs were designed 
for PCSK9 exon 1 in WTC using AlleleAnalyzer. This analysis was done in reference 
genome hg19. 
 
WTC sequencing  
 
The genome for the iPSC line WTC (Drubin and Hyman, 2017) was sequenced by the 
Allen Institute for Cell Science. Analysis and variant calls in the reference genome hg19 
were done according to GATK version 3.7 best practices (Van der Auwera et al., 2013) 
and phased using Beagle version 4.1 with default settings (Browning and Browning, 
2007). 
 
WTC targetability analysis 
 
Variant annotation procedures were the same as in the 1KGP analysis and ExAc.   
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Packages used 
 
Python 
 
Docopt was used for handling of command-line arguments. Pandas (McKinney, 2010) 
version 0.21.0 and NumPy (Stéfan van der Walt, 2011) version 1.13.3 and elements of 
the standard Python distribution sys, os, and regex were used for multiple aspects of 
data analysis. PuLP (Mitchell et al., 2011) version 1.6.8 was used for set cover analysis. 
PyTables (Francesc Alted) was used for data management. Biopython (Cock et al., 
2009) and pyfaidx (Shirley et al., 2015) were used for Fasta processing. Scripts from 
CRISPOR (Haeussler et al., 2016) were integrated into AlleleAnalyzer to facilitate 
specificity scoring of gRNAs. Seaborn (Waskom et al., 2018) and matplotlib (Hunter, 
2007) were used for plotting. 
 
R 
 
Packages used to generate arcplots included viridis version 0.5.1, viridisLite version 
0.3.0, igraph version 1.1.2, ggraph version 1.0.0, ggplot2 version 2.2.1, reshape2 
version 1.4.3, dplyr version 0.7.4, tidyr version 0.7.2, and readr version 1.1.1. 
 
Bioinformatics 
 
Bcftools version 1.9 were used to manipulate VCF and BCF files. 
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Code Availability and Scripts 
 
All data processing and analysis scripts as well as the gRNA design tool are located at 
github.com/keoughkath/AlleleAnalyzer, available under the MIT license (DOI: 
10.5281/zenodo.3354488). Scripts were written in Python version 3.6.1, R version 3.3.2 
and Bash version 3.2.57.  
 
Availability of Data and Materials 
 
1KGP phase 3 data were downloaded from the 1KGP website 
(http://www.internationalgenome.org/). ExAc data were downloaded from the ExAc 
website (http://exac.broadinstitute.org/). The reference hg19 and hg38 genome data 
were downloaded from the UCSC genome browser. The 1KGP and ExAc analysis 
datasets have been made available for public access online at UCSF Dash 
(https://datashare.ucsf.edu/stash/dataset/doi:10.7272/Q63F4MSR). Additionally, PAM 
sites identified in reference genomes hg19 and hg38 are viewable in UCSC Browser 
sessions (hg19: https://bit.ly/2GB9cXK or https://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg19&lastVirtModeType=default&lastVirtModeExtraState=&virtModeT
ype=default&virtMode=0&nonVirtPosition=&position=chr11%3A61717368%2D6171746
8&hgsid=743058527_XLIEJrwnSVsZQLgeXUfU7NKQWeNn 
, hg38: https://bit.ly/2BZAmVh or https://genome.ucsc.edu/cgi-
bin/hgTracks?db=hg38&lastVirtModeType=default&lastVirtModeExtraState=&virtModeT
ype=default&virtMode=0&nonVirtPosition=&position=chr11%3A61957117-
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61957165&hgsid=710108079_SecTcyDrgBPU4AocIPTRF2Uq4Omd). WTC whole-
genome sequencing data is made available by the Allen Institute at 
(https://www.allencell.org/genomics.html). In addition to the Github repository for 
AlleleAnalyzer (github.com/keoughkath/AlleleAnalyzer, available under the MIT license), 
an archived release of the software is available under DOI:10.5281/zenodo.3354488 
provided through Zenodo.  
3 Investigation of the driving forces behind accelerated evolution 
in humans 
 
Comparing genomic sequences within and among species enables the identification of 
regions of the genome that are conserved or accelerated, indicating what types of 
selective pressures may be acting on those loci (Pollard et al., 2010). In addition to 
defining evolutionary pressures causing evolution of protein-coding genes, evidence of 
selective pressures in the noncoding genome help us develop theories about the 
various functions of DNA that does not produce proteins. Elements that are conserved 
in the noncoding genome can indicate the presence of functional elements such as 
enhancers, promoters, noncoding RNAs, transcription factor binding sites and motifs 
important for the proper folding of the genome (for a review of these elements, see 
(Chatterjee and Ahituv, 2017)). Accelerated evolution can help us identify where on a 
phylogenetic tree the selective pressure has changed on these elements, which can 
give us insight on how these features contribute towards the unique features of each 
species.  
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Evolution happens both at the sequence and the organizational level, as evidenced by 
differences in 3D genomic structure between various species, such as human and 
closely related primates (Eres et al., 2019). These changes in genome structure can 
rewire regulatory circuits, for example by placing enhancers in contact with genes they 
did not previously regulate, termed “enhancer hijacking” (Northcott et al., 2014). Within 
humans, enhancer hijacking has been demonstrated to cause various types of 
polydactyly and be involved in cancer (Lupiáñez et al., 2016). In this chapter, I describe 
various projects I contributed to relating to genome evolution in 1D (sequence-based) 
and 3D (structure-based).  
 
3.1 Human accelerated regions in psychiatric disease 
 
Human accelerated regions (HARs) are genomic loci that are conserved in many 
species but demonstrate uniquely accelerated sequence evolution in humans (Franchini 
and Pollard, 2017; Hubisz and Pollard, 2014; Pollard et al., 2006a). Many of these loci 
function as enhancers, while some function as noncoding RNAs and other have 
currently unknown functions. During my tenure as a graduate student, I contributed to 
multiple projects exploring the function of these regions, and initiated a new project to 
investigate the genomic forces driving their accelerated sequence evolution. 
In one project, I contributed to we used massively parallel reporter assays (MPRAs) to 
assess the enhancer activity of hundreds of HARs by attaching them to reported genes 
and infecting them into neural progenitor cells from human and chimpanzees (Ryu et 
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al., 2018).  In order to predict putative target genes for HARs that demonstrated strong 
enhancer activity I used Hi-C data from biologically relevant cell types (human fetal 
brain germinal zone and cortical plate tissue (de la Torre-Ubieta et al., 2018)) to identify 
genes in the same topological associating domains (TADs) with HARs. TADs are 
genomic regions that interact highly with each other in 3D space (Dixon et al., 2012; 
Nora et al., 2012). This information was combined with RNA sequencing (RNA-seq) 
data in order to assign putative activate cell types for HARs based on expression of 
genes in the same TAD in different cell types. GWAS SNPs were also assigned to 
HARs based on co-occurrence in the same TADs, thereby providing new hypotheses 
about potential roles for HARs in the associated disease. This approach enabled more 
informed discovery of target genes, whereas previous approaches relied on “nearest 
gene” approach, although we now know that many enhancers do not act on their 
nearest gene.  
 
Through these combined analyses, I discovered that 2XHAR.170 contains a SNP 
associated with schizophrenia by genome-wide association study (GWAS), a technique 
that identifies genomic variants significantly associated with a particular phenotype in a 
large cohort of individuals. Because HARs are highly conserved for the most part 
among humans, it is unlikely to find many variants that occur at a high enough allele 
frequency so as to be genome-wide significant for a disease association. Thus, 
finding rs2434531, a variant that is associated with schizophrenia in the sequence of 
the 2xHAR.170, is notable, even though at a p-value of 7.47e-8, this SNP just misses 
the cutoff for genome-wide significance (Pouget et al., 2016). Notably, rs2434531 is in 
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an LD block with a genome-wide significant SNP, rs11740474 (Forrest et al., 2017). 
SNP rs2434531 has minor allele frequency ~23% in 1000 Genomes and TOPMED, with 
the human-derived nucleotide (C) being more common than the ancestral (i.e., 
matching chimp) nucleotide (T). This HAR resides in the first intron of the 
gene GALNT10. Beyond its accelerated evolution, 2xHAR.170 displays other markers 
of a potential enhancer in many cell types, including neuronal, based on ChromHMM 
(Ernst and Kellis, 2017). It also binds FOXP2, a transcription factor widely associated 
with schizophrenia. 2xHAR.170 drives significantly higher expression with the human as 
opposed to the chimp sequence in our assay. This matches results from eQTL studies 
of rs2434531 
for GALNT10 [http://eqtl.rc.fas.harvard.edu/eqtlbrowser/mrcau133list/19443]. 
Interestingly, GALNT10 has been shown to be significantly more highly expressed in 
cases of schizophrenia compared to controls (Voisey et al., 2017). Therefore, while 
these relationships may indicate a previously unknown link between 2xHAR.170 and 
schizophrenia, it is clear that the link is complex, consistent with its associated disease. 
 
3.2 Methodological considerations for calling HARs in an era of many genomes 
 
HARs were first identified using a multiple alignment of 29 vertebrate genomes (Pollard 
et al., 2006a, 2006b). Since then, new sequencing technologies have led to an 
explosion in available species genomes, enabling the assessment of factors in the 
pipeline that impact which genomic loci are identified as HARs. Indeed, HARs have 
been identified with multiple pipelines and datasets, and tend to show low levels of 
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overlap. I assembled a pipeline to call HARs that enables easy tuning of parameters 
and analysis of the impact of various decision made throughout the pipeline. 
Using a 100-way vertebrate alignment from UCSC, I implemented the HAR pipeline laid 
out in the original HAR publication using Nextflow, a pipeline management software that 
enables greater modularity and reproducibility for multi-step analyses (Di Tommaso et 
al., 2017; Pollard et al., 2006a, 2006b). This pipeline was applied to a 100-way 
alignment of vertebrate species from UCSC. When applied to all 100 species in the 
alignment, 7,153 HARs were found. However, it is known that errors in assembly can be 
influential when identifying accelerated sequence evolution, because assembly errors 
and acceleration can look similar. Therefore, using assembly quality metrics and 
optimizing representation throughout the vertebrate tree, I defined a set of fifty-two 
“high-quality” sequences and ran the HAR identification pipeline on an alignment filtered 
for only those species. This resulted in a smaller set of 110 HARs (Benjamini-Hochberg-
corrected p-value < 0.01) that demonstrated greater proportional overlap with previous 
sets (Figure 11: HAR set comparisons), such as from an analysis of 29 mammals 
(Broad Institute Sequencing Platform and Whole Genome Assembly Team et al., 2011) 
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and the original HAR 
set (Pollard et al., 
2006a, 2010). 
Additionally, a 
greater proportion of 
the HARs from high-
quality species 
assemblies had 
evidence for positive 
selection using a 
method optimized 
for analysis in the noncoding genome, indicating that I may have filtered out more 
instances of loss of negative selection by focusing on species with higher quality data 
(Kostka et al., 2012). Therefore, I learned that sequence and assembly quality are 
important in identifying regions undergoing species-specific accelerated evolution, and 
identified an updated set of HARs along with principles to guide identification of 
sequence evolution when the number of genomes is not the limiting factor. 
 
3.3 Changes in the 3D genome may influence the evolutionary rate of HARs 
Structural variants can change the 3D structure of the genome, for example by 
removing TAD boundaries. This in turn can rewire regulatory networks by generating 
interactions between enhancers and genes that had not previously interacted. This 
phenomenon, termed “enhancer hijacking”, has been implicated in various cancers and 
Figure 11: HAR set comparisons 
Analysis of basepairs of overlap between various HAR sets. 
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polydactyly-related diseases (Lupiáñez et al., 2016). Structural variation also occurs 
over evolutionary time, inserting, rearranging, and removing loci, and meanwhile 
changing the 3D and regulatory networks of the genome. Recent work generated high 
quality assemblies for 
chimpanzee and 
orangutan, and 
compared these along 
with a high-quality gorilla 
genome to the human 
genome, identifying 
many human-specific 
insertions and deletions 
(Kronenberg et al., 
2018). 
 
Our hypothesis is that in 
some cases human-specific structural variants put human accelerated regions in 
contact with genes they did not previously regulate that were important for human-
specific traits, thus generating the selective pressure to induce accelerated rates of 
evolution at these loci. To investigate this, I assessed whether TADs that contain 
human-specific structural variants are enriched for HARs.  Using TADs called in N2-
neural progenitor cells, I compared the odds ratios of HARs being in TADs with human-
specific SVs compared to that of sets of randomly drawn phastCons elements equal to 
Figure 12: HAR enrichment in TADs with human-specific 
SVs 
Blue shaded region indicates the null distribution generated 
by calculating the odds ratios of the number of HARs sized 
sets of phastCons elements co-occurring in the same TAD 
with human-specific SVs, randomly selected 1000 times. The 
magenta line indicates the actual odds ratio for HARs.  
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the number of HARs, drawn 1000 times 
as a null model. Based on this, I found 
that TADs with human-specific structural 
variants are significantly enriched for 
HARs (Figure 12). This supports our 
hypothesis that human-specific SVs and 
HARs may be impacting each other.  
 
3.4 Human-specific SVs near HARs 
are predicted to alter 3D genome 
structure 
 
Our hypothesis that a similar 
mechanism to enhancer hijacking may 
have contributed to the acceleration of 
HARs depends on human-specific SVs 
altering 3D genome structure, for 
instance by removing or altering TAD 
boundaries. This is difficult to study via 
comparative analysis in relevant tissues 
and cell types in human and 
chimpanzee due to scarcity of samples 
and technical challenges, although this 
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Figure 13: Predicted impact of a human-
specific SV on 3D genome conformation 
Akita-predicted 3D genome changes due to a 
human-specific deletion in the chimpanzee 
genome, with enhancer-related epigenetic and 
gene data for the locus. 
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is something we are working towards. However, deep learning models have recently 
been developed that are capable of predicting 3D genome structure based on DNA 
sequence alone. One of these models, Akita, was developed in the Pollard lab and has 
been able to accurately reconstruct the impact of SVs in the human genome 
(Fudenberg et al., 2019). Using this model, I was able to identify human-specific SVs 
that are predicted to significantly alter 3D genomes structure near a HAR. For example, 
3XHAR.193 is located near a human-specific deletion on chromosome 15. Using Akita, I 
predicted and visualized the impact of this deletion in the chimpanzee genome, finding 
that the deletion is predicted to disrupt a sub-TAD structure within a larger TAD, 
decreasing its contact frequency to that of the surrounding TAD (Figure 13). This 
disrupts chromatin patterns that previously insulated 3XHAR.193 from nearby genes, 
such as aldehyde dehydrogenase 1 family member A2 (ALDH1A2), a gene with some 
expression in the adult human brain (GTex), and important for neural tube development. 
This HAR has been predicted to be a brain enhancer and has epigenetic marks 
consistent with higher enhancer activity in human relative to rhesus macaque (Capra et 
al., 2013; Vermunt et al., 2016). Additionally, our comparative analyses indicate this 
HAR as being under positive selection, supporting the idea that this locus gained 
increased enhancer activity specifically in the human lineage, with potential beneficial 
effects towards human brain development. 
 
Overall, more work is needed to prove or refute the hypothesis of a role for human-
specific SVs or enhancer hijacking in HAR acceleration, but these analyses lay the 
groundwork for future hypothesis testing and experimentation.  
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4 Comparative genomics to identify the host range for SARS-
CoV2 
 
The work described in this chapter is currently available as a preprint on BioRxiv and is 
under peer review (Damas et al., 2020). I was able to apply the skills I had learned 
during projects focused mainly on human evolution and disease to co-lead a manuscript 
to predict host species for SARS-CoV2, the virus that upended the world beginning in 
2019 and caused me to write this thesis entirely sequestered at home. My main 
contributions to the paper were the PHAST and phyloP-based selection analyses 
(Hubisz et al., 2011; Pollard et al., 2010; Ramani et al., 2019). The paper represented a 
sprint effort by 19 authors from universities, zoos, and research institutions all over the 
world.  
 
The novel coronavirus SARS-CoV-2 is the cause of COVID-19, a major pandemic that 
threatens millions of human lives and the global economy, with infections now reported 
in other species as well.  We identified a large number of mammals that can potentially 
be infected by SARS-CoV-2 through their ACE2 proteins, which can assist identification 
of an intermediate host(s) for SARS-CoV-2 and hence reduce the opportunity of a future 
outbreak of COVID-19. Among the highest risk species for SARS-CoV-2 infection using 
ACE2 are wildlife species and endangered species.  These species represent an 
opportunity for spillover of SARS-CoV-2 from humans to other susceptible animals, and 
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should thus be a focus of surveillance and conservation efforts.  The impact of this work 
is likely to inform COVID-19-related conservation efforts for endangered species, 
protective measures between humans and other species, and model-animal selection 
for COVID vaccine and therapeutic development. 
 
4.1 Justification for a comparative analysis of ACE2 in vertebrates 
 
The 2019-novel coronavirus (2019-nCoV, also, SARS-CoV-2 and COVID-19 virus) is 
the cause of Coronavirus Disease-2019 (COVID-19), a major pandemic that threatens 
millions of lives and the global economy (Zhou et al., 2020).  Comparative analysis of 
SARS-CoV-2 and related coronavirus sequences has shown that SARS-CoV and 
SARS-CoV-2 likely originated in bats, followed by transmission to an intermediate host, 
and that both viruses may have an extended host range that includes primates and 
other mammals (Lu et al., 2015; Shan et al.; Zhou et al., 2020). However, the immediate 
source population/species for SARS-CoV and SARS-CoV-2 viruses has not yet been 
identified.  Several mammalian species host coronaviruses, and these infections are 
frequently associated with severe clinical diseases, such as respiratory and enteric 
disease in pigs and cattle (Laude et al., 1993; Saif, 2010).  Molecular phylogenetics 
revealed that at least one human coronavirus (HCov-OC43), may have originated in 
cattle or swine (Chen et al., 2005), and that this virus was associated with a human 
pandemic that emerged in the late 19th century (Vijgen et al., 2005).  Recent data 
indicate that coronaviruses can move from bats to other wildlife species and humans 
(Lam et al., 2020) and from humans to tigers (United States Department of Agriculture 
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Animal and Plant Health Inspection Service) and pigs (Qian et al., 2013). Therefore, 
understanding the host range of SARS-CoV-2 and related coronaviruses is essential for 
improving our ability to predict and control future pandemics.  It is also crucial for 
protecting populations of wildlife species in native habitats and under human care, 
particularly non-human primates, who may also be susceptible to COVID-19 (Sun et al., 
2020a).   
 
The angiotensin I converting enzyme 2 (ACE2) serves as a functional receptor for the 
spike protein (S) of SARS-CoV and SARS-CoV-2 (Lan et al., 2020; Li et al., 2003). 
Under normal physiological conditions, ACE2 is a dipeptidyl carboxypeptidase that 
catalyzes the conversion of angiotensin I into angiotensin 1-9, a peptide of unknown 
function, and angiotensin II, a vasoconstrictor that is important in the regulation of blood 
pressure (Patel et al., 2016).  ACE2 also converts angiotensin II into angiotensin 1-7, a 
vasodilator that affects the cardiovascular system (Patel et al., 2016) and may regulate 
other components of the renin-angiotensin system (Feng et al., 2008).  The host range 
of SARS-CoV-2 may be extremely broad due to the conservation of ACE2 in mammals 
(Lan et al., 2020; Lu et al., 2015) and its expression on ciliated bronchial epithelial cells 
and type II pneumocytes (Qian et al., 2013). While coronaviruses related to SARS-CoV-
2 use ACE2 as a primary receptor, coronaviruses may use other proteases as 
receptors, such as CD26 (DPP4) for MERS-CoV (Raj et al., 2013), thus limiting or 
extending their host range.   
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In humans, ACE2 may be a cell membrane protein or it may be secreted (Patel et al., 
2016).  The secreted form is created primarily by enzymatic cleavage of surface-bound 
ACE2 by ADAM17 and other proteases (Patel et al., 2016).  Sequence variation in 
ACE2 affects the protein’s functions. ACE2 is polymorphic in humans, with many 
synonymous and nonsynonymous mutations identified, although most are rare at the 
population level (Karczewski et al., 2020) and few are believed to affect cellular 
susceptibility to human coronavirus infections (Stawiski et al., 2020). Site-directed 
mutagenesis and co-precipitation of SARS-CoV constructs have revealed critical 
residues on the ACE2 tertiary structure that are essential for binding to the virus 
receptor binding domain (RBD) (Li, 2013). These findings have been strongly supported 
by co-crystallization and the structural determination of the SARS-CoV and SARS-CoV-
2 S proteins with human ACE2 (Lan et al., 2020; Li et al., 2005; Shang et al., 2020), as 
well as binding-affinity with heterologous ACE2 (Li, 2013). The RBD of human 
coronaviruses may mutate to change the binding affinity of S for ACE2, and thus lead to 
adaptation in humans or other hosts.  The best studied example is the palm civet, 
believed to have been the intermediate host between bats and humans for SARS-
CoV(Lu et al., 2015).  To date, an intermediate host for SARS-CoV-2 has not been 
identified definitively, although Malayan pangolins (Manis javanica) have been proposed 
as a possible reservoir (Zhang et al., 2020). 
 
Comparative analysis of ACE2 nucleotide and protein sequences can predict their 
ability to bind SARS-CoV-2 S and therefore will yield important insights into the biology 
and potential zoonotic transmission of SARS-CoV-2 infection. Recent work has 
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examined ACE2 from different vertebrate species and predicted its ability to bind SARS-
CoV-2 S, but phylogenetic sampling was extremely limited (Liu et al., 2020; Sun et al., 
2020a).  Here, we made use of sequenced genomes of 410 vertebrates and protein 
structural analysis, to identify ACE2 homologs in all vertebrate classes (fishes, 
amphibians, birds, reptiles, and mammals) that have the potential to serve as a receptor 
for SARS-CoV-2, and to understand the evolution of ACE2 SARS-CoV-2 S binding 
sites. Our results reinforce earlier findings on the natural host range of SARS-CoV-2, 
and predict a broader group of species that may serve as a reservoir or intermediate 
host for this virus.  Importantly, many threatened and endangered species were found to 
be at potential risk for SARS-CoV-2 infection, suggesting that as the pandemic spreads, 
humans could inadvertently introduce a potentially devastating new threat to these 
already vulnerable populations, especially for great apes and other primates.  
 
4.2 Comparison of vertebrate ACE2 sequences and their predicted ability to bind 
SARS-CoV-2 based on sequence and structure homology 
 
We identified 410 unique vertebrate species with ACE2 orthologs that included 
representatives of all vertebrate taxonomic classes. Among these were 252 mammals, 
72 birds, 65 fishes, 17 reptiles and 4 amphibians. Twenty-five amino acids 
corresponding to known SARS-CoV-2 S-binding residues (Lan et al., 2020; Shang et 
al., 2020; Sun et al., 2020a) were examined for their similarity to the residues in human 
ACE2 (Figure 14; Error! Reference source not found.). On the basis of known 
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interactions between specific residues on ACE2 and the RBD of SARS-CoV-2 S, a set 
Figure 14: Protein sequence-based score high through low 
Scores for each species based on homology between amino acids sequences for species scoring high 
through low, continued in Figure 14.  
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of rules was developed for predicting the likelihood of S binding to ACE2 from  
Figure 15: Protein sequence-based score low through very low 
Scores for each species based on homology between amino acids sequences (continuation of 
Figure 14 for species scoring low through very low.  
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each species (see Materials and Methods).  Five score categories were predicted: very 
high, high, medium, low and very low. Results for all species and all SARS-CoV-2 S 
binding scores are shown in Dataset S1, and results for mammalian species are also 
shown in Figure 14 and Error! Reference source not found..   
 
We complemented the sequence-identity based scoring scheme with a qualitative 
approach that combined structural homology modeling and best fit rotamer positioning. 
Figure 16: Evaluation of binding contacts between host ACE2 and SARS-CoV-2 
Evaluation of binding contacts between host ACE2 and SARS-CoV-2 in 28 representative species 
selected from very low, low, medium and high binding score groups, and for each residue in the 
ACE2 binding interface that varied from human (55 substitutions in 16 residues). For each residue, 
amino acid substitutions are shown on the left as white boxes, with sites matching human ACE2 
shown in gray. For each residue, the evaluation of the binding contact is shown on the right as 
neutral (N; blue box), weakening (W; orange box); or unfavorable (U; red box), with sites matching 
human ACE2 in blue. Evaluations discordant with Procko (5) are marked with an asterix and lighter 
background color.   
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We examined the 25 ACE2 binding residues in a subset of 28 representative species 
(Figure 16).  First, we assessed the similarity of every contact at the binding interface 
between two recently solved crystal structures for the human ACE2/SARS-CoV-2 S 
RBD complex in humans, 6M0J and 6WV1 (Lan et al., 2020; Shang et al., 2020).    
We examined a total of 55 substitutions and assigned each to one of three types: 
neutral (N;  likely to maintain similar contacts; 18 substitutions); weaken (W; likely to 
weaken the interaction; 14 substitutions); or unfavorable (U; likely to introduce 
unfavorable interactions; 23 substitutions). The structural homology binding 
assessments support the sequence identity analysis, with the fraction of residues 
ranked as U correlating very strongly with the substitution scoring scheme (Spearman 
correlation rho=0.76; p< 2.2e-16; Figure 17). 
 
Figure 17: Congruence between binding score and structural homology analysis 
Species classified by sequence identity to human ACE2 as very high (red) or high binding score (orange) 
have significantly fewer amino acid substitutions rated as potentially altering the binding interface 
between ACE2 and SARS-CoV-2  through protein structural analysis, as compared to low (green) or very 
low (blue) species. The more severe unfavorable variants are counted on y-axis and less severe weaken 
variants on the x-axis. Black numerical labels indicate species count.  
 
4.4 Structural analysis of variation in human ACE2 
 
We applied the same approach used to compare species, sequence identity and protein 
structural analysis, to examine the  variation in ACE binding residues within humans, 
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some of which have been proposed to alter binding affinity (Cao et al., 2020; Hussain et 
al., 2020; Othman et al., 2020; Renieri et al., 2020; Stawiski et al., 2020). We integrated 
data from six different sources: dbSNP (Sherry, 2001), 1KGP (Voight et al., 2015), 
Topmed (NHLBI), UK10K (UK10K Consortium et al., 2015) and CHINAMAP (Cao et al., 
2020), and identified a total of 11 variants in ten of the 25 ACE2 binding residues.  All 
variants found are rare, with allele frequency less than 0.01 in any populations, and less 
than 0.0007 over all populations. Three of the 11 variants were synonymous changes, 
seven were conservative missense variants, and one, S19P, was a semi-conservative 
substitution. S19P has the highest allele frequency of the 11 variants, with a global 
frequency of 0.0003 (Karczewski et al., 2020). We evaluated, by structural homology, 
six missense variants. Four were neutral and two weakening (E35K, 
frequency=0.000016; E35D, frequency=0.000279799). Thus, with an estimated 
summed frequency of 0.001, genetic variation in the ACE2 S-binding interface is overall 
rare, and it is unclear whether the variation that does exist increases or decreases 
susceptibility to infection.  
 
4.5 Evolution of ACE2 across mammals.  
 
We next investigated the evolution of ACE2 variation in vertebrates, including how 
patterns of positive selection compare between bats, a mammalian lineage known to 
harbor a diversity of coronaviruses (Anthony et al., 2017), and other mammalian clades. 
We first inferred the phylogeny of ACE2 using our 410-vertebrate alignment and 
IQTREE, using the best-fit model of sequence evolution (JTT+F+R7) and rooting the 
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topology on fishes. I assayed sequence conservation with PhyloP (36). The majority of 
ACE2 codons are significantly conserved across vertebrates and across mammals, 
likely reflecting its critical function in the renin-angiotensin system (Oudit et al., 2003), 
with ten residues in the ACE2 binding domain exceptionally conserved in Chiroptera 
and/or Rodentia.  
 
We next used phyloP and CODEML to test for acceleration and positive selection with a 
co-author (Graham Hughes) leading the CODEML analyses and me leading the phyloP 
analyses (Pollard et al., 2010). PhyloP compares the rate of evolution at each codon to 
the expected rate in a model estimated from third nucleotide positions of the codon, and 
is agnostic to synonymous versus nonsynonymous substitutions (dN/dS). CODEML 
uses ⍵=dN/dS>1 and Bayes Empirical Bayes (BEB) scores to identify codons under 
Figure 18: Significant results from phyloP, both conserved and accelerated, for ACE2 
codons compared with CODEML BEB scores 
Left panel shows phyloP results for the 64-mammals subset used in the mammal CODEML analysis. 
Right panel shows phyloP results for all mammals in the alignment. The y-axis represents dN/dS 
values calculated by CODEML, x-axis indicates whether the codons were classified as conserved or 
accelerated by phyloP. All dots are significant results from phyloP, blue dots are also significantly 
positively selected from CODEML. 
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positive selection, and was run on a subset of 64 representative mammals (see 
Materials and Methods).  
 
ACE2 shows significant evidence of positive selection across mammals (⍵=1.83, 
LRT=194.13, p<0.001).  Almost 10% of codons (N=73; 9 near the RBD) are accelerated 
within mammals, and 18 of these have BEB scores greater than 0.95, indicating 
positively selected residues (Figure 18). Nineteen accelerated residues, including two 
positively-selected codons (Q24, H34), are critical for the binding of the ACE2 RBD and 
SARS-CoV-2 S (Error! Reference source not found.; Error! Reference source not 
found.).  
 
Figure 19: Residues under positive selection detected with CODEML and acceleration 
with phyloP in mammals 
(A) ACE2 is represented in wheat cartoon with residues involved in the binding interface shown in 
yellow spheres. Dark blue and red spheres indicate residues in ACE2 that are accelerated and under 
positive selection. Red spheres represent residues that overlap with positions in the binding interface 
and are labeled with (*). The spike RBD is shown in light teal cartoon. Green spheres indicate residues 
on the SARS-CoV-2 spike protein under positive selection and are labeled with (**). (B) 90 degree 
rotation of the ACE2 protein. 
 49 
Q24 has not been observed to be polymorphic within the human population, and H34 
harbors a synonymous polymorphism (AF=0.00063) but no non-synonymous 
polymorphisms.  
 
 
This pattern of acceleration and positive selection in ACE2 also holds for individual 
mammalian lineages. Using CODEML, positive selection was detected within the orders 
Chiroptera (LRT=346.40, ⍵=3.44 p<0.001), Cetartiodactyla (LRT=92.86, ⍵=3.83, 
p<0.001), Carnivora (LRT=65.66, ⍵=2.27. p<0.001), Primates (LRT=72.33, ⍵=3.16, 
Figure 20: Residues under accelerated evolution in mammals, overlapping the binding 
interface, as detected using phyloP 
(A) The SARS-CoV-2 spike RBD is shown in light teal cartoon. ACE2 is shown in wheat cartoon with 
residues involved in the binding interface shown in yellow spheres. (*) Dark blue and red spheres 
indicate ACE2 residues that are accelerated, under positive selection and overlapping the binding 
interface. Cyan spheres indicate ACE2 residues that are conserved. (**) Red spheres also 
demonstrate positive selection with CODEML. (B) 90 degree rotation of the ACE2 protein. 
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p<0.001) and Rodentia (LRT=91.26, ⍵=1.77, p<0.001). Overall, bats had more 
Figure 21: Intralineage phyloP results for all ACE2 codons 
PhyloP signal was assessed at all ACE2 codons for various mammalian lineages against neutral models 
trained on those lineages, thereby identifying intralineage signals of shifts in evolutionary rate. Green 
dots indicate codons classified as conserved and blue dots accelerated.  Vertical grey lines indicate 
important binding residues in ACE2. The x-axis indicates the corresponding position in the ACE2 protein 
for each codon, and the y-axis indicates the phyloP p-value for each codon. 
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positively selected sites with significant BEB scores (29 sites in Chiroptera compared to 
Figure 22: PhyloP results for mammalian lineages against a mammal neutral model 
PhyloP signal was assessed at all ACE2 codons for various mammalian lineages against a neutral model trained 
on all mammalian species in the alignment. Green dots indicate codons classified as conserved and blue dots 
accelerated. Vertical grey lines indicate important binding residues in ACE2. The x-axis indicates the 
corresponding position in the ACE2 protein for each codon, and the y-axis indicates the phyloP p-value for each 
codon. 
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10, 8, 7 and 15 sites in Cetartiodactyla, Carnivora, Primates and Rodentia, 
respectively). Positive selection at key sites for the binding of ACE2 and SARS-CoV-2 
was only found in the bat-specific alignment. PhyloP was used to assess shifts in 
evolutionary rate within mammalian lineages, for each assessing signal relative to a 
neutral model trained on species from the specified lineage (Figure 21). We discovered 
six important binding residues, five of which showed evidence for positive selection, that 
are accelerated in one or more of Chiroptera, Rodentia, or Carnivora, with G354 
accelerated in all of these lineages.  
 
Figure 23: Residues under acceleration with phyloP in chiroptera relative to mammals 
(A) The SARS-CoV-2 spike RBD is shown in light teal cartoon. ACE2 is shown in wheat 
cartoon with residues involved in the binding interface shown in yellow spheres. Dark blue 
and red spheres indicate residues that are accelerated in bats relative to mammals. Red 
spheres also overlap the binding interface. (B) 90 degree rotation of the ACE2 protein. 
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Given pervasive signatures of adaptive evolution in ACE2 across mammals, we next 
sought to test if any mammalian lineages are evolving particularly rapidly compared to 
the others. CODEML branch-site tests identified positive selection in both the ancestral 
Chiroptera branch (1 amino acid, ⍵=26.7, LRT= 4.22, p=0.039) and ancestral 
Cetartiodactyla branch (2 amino acids, ⍵=10.38, LRT= 7.89, p=0.004) using 64 
mammals. These residues did not correspond to known viral binding sites. We found no 
evidence for lineage-specific positive selection in the ancestral primate, rodent or 
carnivore lineages. PhyloP identified lineage-specific acceleration in Chiroptera, 
Carnivora, Rodentia, Artiodactyla and Cetaceans relative to mammals (Figure 22). Bats 
have a particularly high level of accelerated evolution (18 codons; p<0.05).  
 
Of these accelerated residues, T27 and M82 are known to be important for binding 
SARS-CoV-2, with some bat subgroups having amino acids predicted to lead to less 
favorable binding of SARS-CoV-2 (Error! Reference source not found.; Error! 
Reference source not found.). Surprisingly, a residue that is conserved overall in our 
410 species alignment and in the mammalian subset, Q728, is perfectly conserved in all 
37 species of bats except for fruit bats (Pteropodidae), which have a substitution from Q 
to E. These results support the theory that ACE2 is under lineage-specific selective 
pressures in bats relative to other mammals. 
 
Positive selection was found using CODEML at sites L455, E484, F490 and S494 in the 
SARS-CoV-2 S sequence (⍵=1.15, LRT=116.7, p<0.001); however, this signal was not 
particularly high, possibly due to the small sample size (N=8). All of these sites lie within 
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or near the ACE2 SARS-CoV-2 S RBD binding sites (Error! Reference source not 
found.) (Andersen et al., 2020).   
 
4.6 Evolution of ACE2 
 
Variation of ACE2 in the human population is rare (Karczewski et al., 2020). We 
examined a large set of ACE2 variants for their potential differences in binding to SARS-
CoV-2 S and their relationship to selected and accelerated sites.  We found rare 
variants that would result in missense mutations in 7 out of the 25 binding 
residues.  Some of those (e.g. E35K with an AF of 0.00001636) could reduce the virus 
binding affinity, thus potentially lowering the susceptibility to the virus in a very small 
fraction of the population. The analysis suggests that some variants (e.g. D38E) might 
not affect the binding while others (e.g. S19P) have uncertain effects. Further studies 
are needed to confirm and correctly address recent discoveries (Cao et al., 2020; 
Hussain et al., 2020; Stawiski et al., 2020) and the data presented here, investigating 
the possible effect of these rare variants in specific populations. 
 
When exploring patterns of codon evolution in ACE2, we found that a number of sites 
are evolving at different rates in the different lineages represented in our 410-species 
vertebrate alignment. Multiple ACE2 RBD residues important for the binding of SARS-
CoV-2 are evolving rapidly across mammals, with two (Q24 and H34) under positive 
selection (Error! Reference source not found.; Error! Reference source not found.). 
Relative to other lineages analyzed, Chiroptera has a greater proportion of accelerated 
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versus conserved residues, particularly at the SARS-CoV-2 S RBD, suggesting the 
possibility of selective forces on these codons in Chiroptera driven by their interactions 
with SARS-CoV-2-like viruses (Figure 21). Indeed, distinct signatures of positive 
selection found in bats and in the SARS-CoV S protein support this hypothesis that bats 
are evolving to tolerate SARS-CoV-2-like viruses.  
 
4.7 Relationship of the ACE2 binding score to known infectivity of SARS-CoV-2 
 
Data on susceptibility of wild animals to SARS-CoV-2 is still very limited. It has been 
reported that a captive Malayan tiger was infected by SARS-CoV-2 (United States 
Department of Agriculture Animal and Plant Health Inspection Service) and that 
domestic cats, ferrets (Shi et al., 2020), rhesus macaques (Munster et al., 2020) and 
Syrian golden hamsters (Chan et al., 2020) are susceptible to experimental infection by 
SARS-CoV-2. These results agree with our predictions of ACE2 binding ability to SARS-
CoV-2 S (Figure 14; Error! Reference source not found.); 4/5 five species with 
demonstrated susceptibility to SARS-CoV-2 score very high (Rhesus macaque) or 
medium (domestic cat, tiger and Golden hamster).  The only inconsistency was 
observed for ferrets, which had a low ACE2 binding score. This inconsistency could be 
related to the high infectivity dose used for experimental infection that likely does not 
correspond to virus exposure in nature. Dogs have low susceptibility to SARS-CoV-2 
under experimental conditions (Shi et al., 2020), and score low for binding of their ACE2 
to SARS-CoV-2 S. However, kidney cell lines derived from dog showed ACE2-
dependent SARS-CoV-2 S entry, suggesting that in vitro experiments may be 
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overestimating true infectivity potential (Hoffmann et al., 2020; Jebb et al., 2019).  Pigs 
(low), ducks (very low) and chickens (very low) were similarly exposed to SARS-CoV-2 
and showed no susceptibility (Shi et al., 2020), providing further support of our 
methodology.  A recent publication reporting that SARS-CoV-2 could use pig, masked 
palm civet and Chinese rufous horseshoe bat ACE2 expressed in HeLa cells were 
inconsistent with our predictions, while data for mouse was in agreement (Zhou et al., 
2020). Indeed, while mouse ACE2 scored very low in our analysis, pig and Chinese 
rufous horseshoe bat score low, while the masked palm civet scored very low.  As for 
the ferret, high-level exposure to the virus in vitro could potentially result in infection via 
low affinity interactions with ACE2.  Another possibility is that other cellular machinery 
present in the human HeLa cells is facilitating the infection, and that infectivity does not 
relate directly to ACE2 differences in these species. Confirmation of in vitro and in vivo 
susceptibility of these species under physiological conditions and with proper controls is 
clearly necessary.  In addition, the expression of ACE2 varies across animal age, cell 
types, tissues and species (Sun et al., 2020b; Xie et al., 2006), which may lead to 
discrepancies between SARS-CoV-2 susceptibility gleaned from experimental infections 
or laboratory experiments and predictions made from the ACE2-based binding score. 
 
4.8 Mammals with high predicted risk of SARS-CoV-2 infection 
 
Of the 19 catarrhine primates analyzed, 18/19 scored very high for binding of their 
ACE2 to SARS-CoV-2 S and one scored high (the Angola colobus); the 18 species 
scoring very high had 25/25 identical binding residues to human ACE2, including rhesus 
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macaques (Macaca mulatta), which are known to be infected by SARS-CoV-2 and 
develop COVID-19-like clinical symptoms (Munster et al., 2020; Shan et al.).  Our 
analysis predicts that all Old World primates are susceptible to infection by SARS-CoV-
2 via their ACE2 receptors. Thus, many of the 21 primate species native to China could 
be a potential reservoir for SARS-CoV-2. The remaining primate species were scored 
as high or medium, with only the Gray mouse lemur and the Philippine tarsier scoring as 
low.  
 
We were surprised to find that all three species of Cervid deer and 12/14 cetacean 
species have high scores for binding of their ACE2s to SARS-CoV-2 S.  There are 18 
species of Cervid deer found in China. Therefore, Cervid deer cannot be ruled out as an 
intermediate host for SARS-CoV-2.  While coronavirus sequences have been found in 
white tailed deer (Alekseev et al., 2008) and gammacoronaviruses have been found in 
beluga whales (Mihindukulasuriya et al., 2008; Schütze, 2016) and bottlenose dolphins 
(Woo et al., 2014) and are associated with respiratory diseases, the cellular receptor 
used by these viruses is not known.   
 
4.9 Other artiodactyls 
 
A relatively large fraction (21/30) of artiodactyl mammals were classified with medium 
score for ACE2 binding to SARS-CoV-2 S.  These include many species that are 
commonly found in Hubei Province and around the world, such as domesticated cattle, 
sheep and goats, as well as many species commonly found in zoos and wildlife parks 
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(e.g., Masai giraffe, okapi, hippopotamus, water buffalo, scimitar horned oryx, and 
Dama gazelle).  Although cattle MDBK cells were shown in one study to be resistant to 
SARS-CoV-2 in vitro (Hoffmann et al., 2020), we propose immediate surveillance of 
common artiodactyl species for SARS-CoV-2 and studies of cellular infectivity, given our 
predictions. If ruminant artiodactyls can serve as a reservoir for SARS-CoV-2, it would 
have significant epidemiological implications as well as implications for food production 
and wildlife management (see below).  It is noteworthy that camels and pigs, known for 
their ability to be infected by coronaviruses (Anthony et al., 2017), both score low in our 
analysis.  These data are consistent with results (discussed above) indicating that pigs 
cannot be infected with SARS-CoV-2 both in vivo (Shi et al., 2020) and in vitro 
(Hoffmann et al., 2020).  
 
4.10 Rodents 
 
Among the rodents, 7/46 species score high for ACE2 binding to SARS-CoV-2 S, with 
the remaining 11, 10 and 18 scoring medium, low or very low, respectively.  Brown rats 
(Rattus norvegicus) and the house mouse (Mus musculus), scored very low, consistent 
with infectivity studies (Hoffmann et al., 2020; Zhou et al., 2020).  Given that wild rodent 
species likely come in contact with bats as well as with other predicted high risk 
species, we urge surveillance of high and medium binding likelihood rodents for the 
presence of SARS-CoV-2.  
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4.11 Bats and other species of interest 
 
Chiroptera (bats) represent a clade of mammals that are of high interest in COVID-19 
research because several bat species are known to harbor coronaviruses, including 
those most closely related to the betacoronavirus SARS-CoV-2 (Zhou et al., 2020).  We 
analyzed ACE2 from 37 bat species of which 8 and 29 scored low and very low, 
respectively.  These results were unexpected because the three Rhinolophus spp. 
including the Chinese rufous horseshoe bat are major suspects in the transmission of 
SARS-CoV-2, or a closely related  virus, to humans (Zhou et al., 2020). Globally, bats 
have been shown to harbour the highest diversity of betacoronaviruses in mammals 
tested (Anthony et al., 2017) and show little pathology carrying these viruses (Banerjee 
et al., 2020). We found evidence for accelerated evolution at six RBD binding domain 
residues within the bat lineage, which is more than in any other lineage tested. Bats 
also had far more sites showing evidence of positive selection, including four binding 
domain residues, compared to other mammalian orders. This suggests that the diversity 
observed in bat ACE2 sequences may be driven by selective pressure from 
coronaviruses. Our results suggest that SARS-CoV-2 is not likely to use the ACE2 
receptor in bats, which challenges a recent study showing that SARS-CoV-2 can infect 
HeLa cells expressing Rhinolophus sinicus ACE2 (Zhou et al., 2020). If bats can be 
infected with SARS-CoV-2, the virus likely uses a different receptor.  For example, the 
MERS-CoV, a betacoronavirus, uses CD26/DPP4 (Raj et al., 2013) while the porcine 
transmissible enteritis virus, an alphacoronavirus uses aminopeptidase N (ANPEP) 
(Delmas et al., 1992). As detailed above, further in vitro and in vivo infectivity studies 
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are required to fully understand the mode of transmission of susceptibility of bats to 
SARS-CoV-2. 
 
4.12 Carnivores 
 
Recent reports of a Malayan tiger and a domestic cat infected by SARS-CoV-2 suggest 
that the virus can be transmitted to other felids (Shi et al., 2020; United States 
Department of Agriculture Animal and Plant Health Inspection Service).  Our results are 
consistent with these studies; 9/9 felids we analyzed scored medium for ACE2 binding 
of SARS-CoV-2 S. However, the masked palm civet (Paguma larvata), a member of the 
Viverridae family that is related to but distinct from Felidae, scored as very low. These 
results are inconsistent with transfection studies using civet ACE2 receptors expressed 
in HeLa cells (Zhou et al., 2020), although these experiments have limitations as 
discussed above.  While carnivores closely related to dogs (dingos, wolves and foxes) 
all scored low, experimental data supporting infection in dogs were inconsistent 
(Hoffmann et al., 2020; Shi et al., 2020; Temmam et al., 2020) so no conclusions can be 
drawn. 
 
4.13 Pangolins 
 
Considerable controversy surrounds reports that pangolins can serve as an 
intermediate host for SARS-CoV-2.  Pangolins were proposed as a possible 
intermediate host (Zhang et al., 2020) and have been shown to harbor related 
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coronaviruses. In our study, ACE2 of Chinese pangolin (Manis pentadactyla), Sunda 
pangolin (Manis javanica), and white bellied pangolin (Phataginus tricuspis) had low or 
very low binding score for SARS-CoV-2 S. Neither experimental infection nor in vitro 
infection with SARS-CoV-2 has been reported for pangolins.  As for ferrets and bats, if 
SARS-CoV-2 infects pangolins it may be using a receptor other than ACE2, based on 
our analysis. 
 
4.14 Other vertebrates 
 
Our analysis of 29 orders of fishes, 29 orders of birds, 3 orders of reptiles and 2 orders 
of amphibians predicts that the ACE2 proteins of species within these vertebrate 
classes are not likely to bind SARS-CoV-2 S. Thus, vertebrate classes other than 
mammals are not likely to be an intermediate host or reservoir for the virus, despite 
predictions reported in a recent study (Qiu et al., 2020), unless SARS-CoV-2 can use 
another receptor for infection.  With many different non-mammal vertebrates sold in the 
seafood and wildlife markets of Asia and elsewhere, it is still important to determine if 
SARS-CoV-2 can be found in non-mammalian vertebrates.  
 
4.15 Relevance to Threatened Species 
 
Among the 103 species that scored very high, high and medium for ACE2 SARS-CoV-2 
S RBD binding, 41 (40%) are classified in one of three ‘Threatened’ categories 
(Vulnerable, Endangered, and Critically Endangered) on the IUCN Red List of 
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Threatened Species, five are classified as Near Threatened, and two species are 
classified as Extinct in the Wild (IUCN, 2019). This represents only a small fraction of 
the threatened species potentially susceptible to SARS-CoV-2. For example, all 20 
catarrhine primate species in our analysis, representing three families (Cercopithecidae, 
Hylobatidae, and Hominidae) scored very high, suggesting that all 185 species of 
catarrhine primates, most of which are classified Threatened (Bosch et al., 2005), are 
potentially susceptible to SARS-CoV-2. Similarly, all three species of deer, 
representatives of a family of ~92 species (Cervidae), scored as high risk, as did 
species representing Cetacea (baleen and toothed whales), and both groups contain a 
number of threatened species. Toothed whales have potential for viral outbreaks and 
have lost function of a gene key to the antiviral response in other mammalian lineages 
(Braun et al., 2015). If they are susceptible to SARS-CoV-2 , human-to-animal 
transmission could pose a risk through sewage outfall (Bosch et al., 2005) and 
contaminated refuse from cities, commercial vessels and cruise liners (Copeland, 
2005). In contrast, some threatened species scored  low or very low, such as the giant 
panda (low), potentially positive news for these at risk populations. 
 
Our results have practical implications for populations of threatened species in the wild 
and those under human care (including those in zoos). Established guidelines for 
minimizing potential human to animal transmission should be implemented and strictly 
followed. Guidelines for field researchers working on great apes established by the 
IUCN have been in place since 2015 in response to previous human disease outbreaks 
(Gilardi et al., 2015) and have received renewed attention because of SARS-CoV-2 
 63 
(Estrada et al., 2017; Gilardi et al., 2015; Gillespie and Leendertz, 2020). For zoos, 
guidelines in response to SARS-CoV-2 have been distributed by several Taxon 
Advisory Groups of the North American Association of Zoos and Aquariums (AZA), the 
American Association of Zoo Veterinarians (AAZV), and the European Association of 
Zoo and Wildlife Veterinarians (EAZWV), and these organizations are actively 
monitoring and updating knowledge of species in human care considered to be 
potentially sensitive to infection (A. Lecu, M. Bertelsen, C. Walzer, EAZWV Infectious 
Diseases Working Group, 2020; J. Johnson, A. Moresco, S. Han, 2020). Although in 
silico studies suggest potential susceptibility of diverse species, verification of infection 
potential is warranted, using cell cultures, stem cells, organoids, and other methods that 
do not require direct animal infection studies. Zoos and other facilities that maintain 
living animal collections are in a position to provide such samples for generating crucial 
research resources by banking tissues, and cryobanking viable cell cultures in support 
of these efforts.  
 
4.16 Animal models for COVID-19 
 
A variety of animal models have been developed for studying SARS and MERS 
coronavirus infections (Sutton and Subbarao, 2015). Presently, there is a tremendous 
need for animal models for studying SARS-CoV-2 infection and pathogenesis, as the 
only species currently known to be infected and show similar symptoms of COVID-19 is 
rhesus macaque. Non-human primate models have proven to be highly valuable for 
other infectious diseases, but are expensive to maintain and numbers of experimental 
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animals are limited.  Our results provide an extended list of potential species that might 
be useful as animal models for SARS-CoV-2 infection and pathogenesis, including 
Chinese hamster and Syrian/Golden hamster (Chan et al., 2020), and large animals 
maintained for biomedical and agricultural research (e.g., domesticated sheep and 
cattle).  
 
4.17 Conclusions 
 
We predict that species scored as very high and high for SARS-CoV-2 S binding to 
ACE2 will have a high probability of becoming infected by the virus. We also predict that 
many species having a medium score have some risk of infection, and species scored 
as very low and low are unlikely to be infected by SARS-CoV-2 via the ACE2 receptor. 
Importantly, our predictions are based solely on in silico analyses and must be 
confirmed by direct experimental data.  Until such time, other than for species in which 
SARS-CoV-2 infection has been demonstrated to occur using ACE2, we urge caution 
not to over-interpret the predictions made in the present study. This is especially 
important with regards to species, endangered or otherwise, in human care. While 
species ranked high or medium may be susceptible to infection based on the features of 
their ACE2 residues, pathological outcomes may be very different among species 
depending on other mechanisms that could affect virus replication and spread to target 
cells, tissues, and organs within the host. Furthermore, we cannot exclude the 
possibility that infection in any species occurs via another cellular receptor, as has been 
shown for other betacoronaviruses.  Nonetheless, our predictions provide a useful 
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starting point for selection of appropriate animal models for COVID-19 research and for 
identification of species that may be at risk for human-to-animal or animal-to-animal 
transmissions by SARS-CoV-2.  The approach we used for ACE2 can be extended to 
other cellular proteins known to be involved in coronavirus infection and immunity to 
better understand infection, transmission, inflammatory responses and disease 
progression. 
 
4.18 Methods 
 
Angiotensin I converting enzyme 2 (ACE2) coding and protein sequences 
 
All human ACE2 orthologs for vertebrate species, and their respective coding 
sequences, were retrieved from NCBI Protein (March 20, 2020) (NCBI Resource 
Coordinators, 2016). ACE2 coding DNA sequences were extracted from available or 
recently sequenced unpublished genome assemblies for 123 other mammalian species, 
with the help of genome alignments and the human or within-family ACE2 orthologs. 
The protein sequences were predicted using AUGUSTUS v3.3.2 (Mario Stanke, 2005) 
or CESAR v2.0 (Sharma et al., 2017) and the translated protein sequences were 
checked against the human ACE2 orthologue. ACE2 gene predictions were inspected 
and manually curated if necessary. For four bat species (Micronycteris hirsuta, 
Mormoops blainvillei, Tadarida brasiliensis and Pteronotus parnellii) the ACE2 coding 
region was split into two scaffolds which were merged, and for Eonycteris spelaea a 
putative 1bp frameshift base error was corrected. Eighty ACE2 predictions were 
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obtained from the Zoonomia project, 19 from the Hiller Lab, 12 from the Koepfli lab, 8 
from the Lewin lab and 4 from the Zhou lab. The source, and accession numbers for the 
genomes or proteins retrieved from NCBI are listed in Dataset S1. The final set of ACE2 
sequences comprises 410 vertebrate species. To assure alignment robustness, the full 
set of coding and protein sequences were aligned independently using Clustal Omega 
(Sievers and Higgins, 2014), MUSCLE (Tabebordbar et al., 2016) and COBALT 
(Papadopoulos and Agarwala, 2007) all with default parameters. All resulting protein 
alignments were identical. Clustal Omega alignments were used in the subsequent 
analysis. Each amino acid replacement present in our dataset was classified as neutral, 
semi-conservative and non-conservative as in Clustal Omega. 
 
Identification of ACE2 residues involved in binding to SARS-CoV-2 S protein 
 
We identified 22 ACE2 protein residues that were previously reported to be critical for 
the effective binding of ACE2 RBD and SARS-CoV-2 S (Lan et al., 2020; Shang et al., 
2020). These residues include S19, Q24, T27, F28, D30, K31, H34, E35, E37, D38, 
Y41, Q42, L45, L79, M82, Y83, N330, K353, G354, D355, R357, and R393. All these 
residues were identified from the co-crystallization and structural determination of 
SARS-CoV-2 S and ACE2 RBD (Lan et al., 2020; Shang et al., 2020). The known 
human ACE2 RBD glycosylation sites N53, N90 and N322 were also included in the 
analyzed residue set (Sun et al., 2020a). 
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ACE2 and SARS-CoV-2 binding ability prediction 
 
Based on the known interactions of ACE2 and SARS-CoV-2 residues, we developed a 
set of rules for predicting the likelihood of the SARS-CoV-2 S binding to ACE2. Each 
species was classified in one of five categories: very high, high, medium, low or very 
low likelihood of binding SARS-CoV-2 S. Species in the very high category have at least 
23/25 critical residues identical to the human; have K353, K31, E35, M82, N53, N90 and 
N322; do not have N79; and have only conservative substitutions among the non-
identical 2/25 residues. Species in the high group have at least 20/25 residues identical 
to the human; have K353; have only conservative substitutions at K31 and E35; do not 
have N79; and can only have one non-conservative substitution among the 5/25 non-
identical residues. Species scoring medium have at least 20/25 residues identical to the 
human; can only have conservative substitutions at K353, K31, and E35; and can have 
up to two non-conservative substitutions in the 5/25 non-identical residues. Species in 
the low category have at least 18/25 residues identical to the human; can only have 
conservative substitutions at K353; can have up to three non-conservative substitutions 
on the remaining 7/25 non-identical residues. Lastly, species in the very low group have 
less than 18/25 residues identical to the human or have at least four non-conservative 
substitutions in the non-identical residues. 
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Protein structure analysis 
 
We applied an orthogonal approach to assess the likelihood of binding of a sampling of 
species that were predicted to bind SARS-CoV-2 across the categories of high, 
medium, low or very low likelihood of binding. ACE2 amino acid sequences from 28 
species were extracted from the multiway alignment and loaded into SWISS-MODEL 
(Waterhouse et al., 2018) in order to generate homology derived models.  The output 
files were aligned to the crystal structure 6MOJ (Lan et al., 2020) in order to assess the 
overall similarities to human ACE2. We used two recently solved crystal structures of 
the complex for ACE2 and SARS-CoV-2 S RBD, 6MOJ (Lan et al., 2020) and 6VW1 
(Shang et al., 2020) as ground truth for the human ACE2/SARS-CoV-2 S interaction. In 
the program CHIMERA (Pettersen et al., 2004), we utilized the rotamer function to 
model each individual variant that species exhibit separately, and chose the rotamer 
with the least number of clashes, retaining the most initial hydrogen bonds and 
containing the highest probability of formation as calculated by CHIMERA from the 
Dunbrack 2010 backbone-dependent rotamer library (Shapovalov and Dunbrack, 2011). 
The rotamer was then evaluated in the context of its structural environment and 
assigned a score based on likelihood of interface disruption. Neutral (N) was assigned if 
the residue maintained a similar environment as the original residue, and was predicted 
to maintain or in some cases increase affinity. Weakened (W) was assigned if 
hydrophobic contacts were lost and contacts that appear disruptive are introduced that 
are not technically clashes. Unfavorable (U) was assigned if clashes are introduced 
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and/or a hydrogen bond is broken. Additional structural visualizations were generated in 
Pymol (PyMOL).  
 
Human variants analysis 
 
All variants at the 25 residues critical for effective SARS-CoV-2-ACE2 binding (Lan et 
al.; Shang et al., 2020; Sun et al., 2020a) were compiled from from dbSNP (Sherry, 
2001), 1KGP (Voight et al., 2015), Topmed (NHLBI), UK10K (UK10K Consortium et al., 
2015) and CHINAMAP (28). Specific population frequencies were obtained from 
gnomAD v.2.1.1 (Karczewski et al., 2020). 
 
Phylogenetic reconstruction of the vertebrate ACE2 species tree 
 
The multiple sequence alignment of 410 ACE2 orthologous protein sequences from 
mammals, birds, fishes, reptiles and amphibians was used to generate a gene tree 
using the maximum likelihood method of reconstruction, as implemented in IQTREE 
(Minh et al., 2020). The best fit model of sequence evolution was determined using 
ModelFinder (Kalyaanamoorthy et al., 2017) and used to generate the species 
phylogeny. A total of 1000 bootstrap replicates were used to determine node support 
using UFBoot (Hoang et al., 2018). 
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Identifying sites undergoing positive selection 
 
Signatures of site-specific positive selection in the ACE2 receptor were explored using 
CODEML, part of the Phylogenetic Analysis using Maximum Likelihood (PAML, (Yang, 
2007)) suite of software. Given CODEML’s computational complexity, a smaller subset 
of mammalian taxa (N=64, Dataset S1), which included species from all prediction 
categories mentioned above, was used for selection analyses. To calculate likelihood-
derived dN/dS rates (⍵), CODEML utilises both a species tree and a codon alignment. 
The species tree for all 64 taxa was calculated using IQTREE (Minh et al., 2020) and 
the inferred best-fit model of sequence evolution (JTT+F+R4). This gene topology was 
generally in agreement with the 410 taxa tree, however bats were now sister taxa to 
Perissodactyla. Therefore all selection analyses were run using both the inferred gene 
tree, and a modified tree with the position of bats manually modified to reflect the 410 
taxa topology. All species trees used were unrooted. A codon alignment of the 64 
mammals was generated using pal2nal (Suyama et al., 2006) with protein alignments 
generated with Clustal Omega (Sievers and Higgins, 2014) and their respective CDS 
sequences. 
 
Site-models M7 (null model) and M8 (alternative model) were used to identify ACE2 
sites undergoing positive selection in mammals. Both M7 and M8 estimate ⍵ using a 
beta distribution and 10 rate categories per site with ⍵<=1 (neutral or purifying 
selection), but with an additional 11th category allowing ⍵ >1 (positive selection) in M8. 
A likelihood ratio test (LRT) calculated as 2*(lnLalt – lnLnull), comparing the fit of both null 
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and alternative model likelihoods was carried out, with a p-value calculated assuming a 
chi-squared distribution. Sites showing evidence of positive selection were identified by 
a significant (>0.95) Bayes Empirical Bayes (BEB) score, and validated by visual 
inspection of the protein alignment. To explore order-specific instances of positive 
selection, separate multiple sequence alignments and gene trees for Chiroptera (N=37), 
Cetartiodactyla (N=45), Carnivora (N=44), Rodentia (N=46) and Primates (N=39) were 
also generated and explored using M7 vs. M8 in CODEML.    
 
In addition to site-models, branch-site model A1 (null model) and model A (alternative 
model) were also implemented targeting various mammalian orders, specifically 
Chiroptera, Cetartiodactyla, Rodentia and Primates, to identify lineage-specific positive 
selection in the ACE2 receptor sequence. Branch-site Model A1 constrains both the 
target foreground branch (Carnivora, Chiroptera, Cetartiodactyla, Rodentia and 
Primates) and background branches to ⍵<=1, while the alternative Model A allows 
positive selection to occur in the foreground branch. Null and alternative models were 
compared using LRTs as above, with significant BEB sites identified. 
 
We also looked for positively selected sites in the viral spike protein, using SARS-CoV-2 
(MN908947.3), Bat coronavirus RaTg13 (MN996532.1), Bat SARS-like coronavirus 
isolate Rs4231 (KY417146.1), SARS-related coronavirus strain BtKY72 (KY352407.1), 
SARS coronavirus Urbani (AY278741.1), SARS coronavirus PC4-227 (AY613950.1), 
Coronavirus BtRs-BetaCoV/YN2018B (MK211376.1) and the more divergent Bat Hp-
betacoronavirus/Zhejiang2013 (NC_025217.1) viral strains. Protein and codon 
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alignments were generated as above, with the viral species tree inferred using full 
genome alignments of all strains generated with Clustal Omega (Sievers and Higgins, 
2014). Site-test models were applied using CODEML, and significant BEB sites 
identified. 
 
Analysis for departure from neutral evolutionary rate in ACE2 with PHAST 
 
Neutral models were trained on the specified species sets using the REV nucleotide 
substitution model implemented in phyloFit using an expectation maximization algorithm 
for parameter optimization. The neutral model fit was based on third codon positions to 
approximate the neutral evolution rate specific to the ACE2 gene, using a 410-species 
phylogenetic tree generated by IQTREE as described above and rooted on fishes. The 
program phyloP was then used to identify codons undergoing accelerated or conserved 
evolution relative to the neutral model using --features to specify codons, --method LRT 
--mode CONACC, and --subtree for lineage-specific tests, with p-values thus assigned 
per codon based on a likelihood ratio test. P-values were corrected for multiple testing 
using the Benjamini-Hochberg method (Pollard et al., 2010) and sites with a corrected 
p-value less than 0.05 were considered significant. PhyloFit and phyloP are both part of 
the PHAST package v1.4 (Hubisz et al., 2011; Ramani et al., 2019). 
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5 Investigating the role of lamina associated domains in 
establishment and maintenance of cell identity 
 
The work below reflects a manuscript currently in preparation for submission. The work 
is a collaboration with the Jain lab at the University of Pennsylvania, particularly Parisha 
Shah, who generated all of the unpublished data in the manuscript. Parisha and I are 
co-leading this project, with her leading the experimental side and me leading the 
computational analysis. 
 
5.1 Introduction 
 
Adult human bodies are composed of trillions of cells, comprising more than 200 distinct 
cell types, which are faithfully established and maintained throughout a healthy lifespan. 
Identifying and understanding molecular mechanisms regulating establishment and 
maintenance over time of cellular identity are areas of intense interest. In particular, 
understanding how cell type specific responses are achieved – the ability of a cell to 
respond to specific stimuli to differentiate or to attenuate a stimulus response to 
maintain established identity – is fundamental to understanding cellular diversity. 
  
Many decades of study have uncovered unique cell type-specific transcriptional profiles. 
While these distinct transcriptomes underscore the diversity of cellular function, it 
remains incompletely understood how such coordinated genome-wide transcriptional 
regulation is achieved during development. In vitro differentiation models have identified 
 74 
key signaling molecules and stimuli that function at branch-points of differentiation 
pathways, revealing delicate and complex processes involving lineage-specific 
enhancers and resulting in cell type-specific gene patterning (Takahashi et al., 2007). 
Though important for understanding key developmental cues, these models do not 
capture the full complexity of genome-wide transcriptional regulation or maintenance of 
cellular identity over chronological time. 
 
Three-dimensional genome organization has emerged as a potential mechanism to 
coordinate cell-type specific gene regulation and maintain cell type transcriptional 
fidelity. In particular, genome organization at the nuclear periphery may provide a key 
platform for cell type-specific transcription. The nuclear lamina is a filamentous network 
of lamins A/C, B1, and B2 proteins residing on the inner surface of the nuclear envelope 
(Burke and Stewart, 2006; Worman and Bonne, 2007). A large proportion of the 
genome is localized towards the lamina, termed lamina-associated domains (LADs), 
which range in size from hundreds of kilobases to megabases (Guelen et al., 2008). 
These loci are generally heterochromatic, and genes within LADs are generally 
transcriptionally repressed and undergo active silencing, while genes away from the 
lamina are more often competent for transcriptional activation (Guelen et al., 2008). In 
some cell types, the chromatin is naturally inverted, and this inversion can be generated 
by ablation of nuclear lamin genes, indicating an active role for lamins in anchoring 
LADs to the nuclear periphery (Solovei et al., 2013). The degree of conservation of 
LADs between cell types and species implies an important role for these loci (Guelen et 
al., 2008; Meuleman et al., 2013). Our group and others have shown that spatial LAD 
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positioning regulates organogenesis and show a high degree of transcriptional 
repression (Peric-Hupkes et al., 2010; Poleshko et al., 2017; Robson et al., 2019). In 
particular, subsets of LADs are repositioned away from or to the lamina during 
differentiation in a cell type-specific manner (Peric-Hupkes et al., 2010). During mESC 
neuronal differentiation model, key neuronal genes lose lamina occupancy in neuronal 
precursor cells (Meuleman et al., 2013), and a similar phenomenon is observed during 
mESC cardiac differentiation (Poleshko et al., 2017). Likewise, preventing normal 
“release” of LAD-bound chromatin impacts normal mESC cardiac differentiation 
(Poleshko et al., 2017). These studies underscore the biological relevance of nuclear 
organization and changes therein, but are limited in scope to individual differentiation 
pathways or cell types.  
 
An additional question is how peripheral chromatin itself is organized. An intriguing 
finding from previous studies suggests that a subset of LADs have varying 
characteristics – reduced lamin occupancy and increased gene density compared to 
other LADs, indicating that the concept of a LAD as a monolithic block needs to be 
revised. Work in single cells has shown the frequency at which LADs contact the 
nuclear lamina varies by locus, and correlates with gene density, implicating a structural 
role for LADs with higher contact frequency (Kind et al., 2015). Also, only a subset of 
LADs re-position away from the lamina during differentiation, and individual genomic 
regions have varying probabilities of becoming re-localized to or from the nuclear lamina 
(Kind et al., 2013, 2015). Moreover, chromatin at the nuclear periphery is frequently 
marked by the histone modification H3K9me2, and genomic loci enriched for this signal 
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have been shown to have a high degree, but not perfect, overlap with LADs (Poleshko 
et al., 2017). These results raise the intriguing possibility that peripheral 
heterochromatin may comprise distinct compartments defined by unique sets of 
features. Defining these various categories of peripheral chromatin domains across 
multiple cell types, and characterizing distinct or dynamic subtypes of those features, 
will provide critical knowledge about how peripheral chromatin is organized and how 
nuclear organization regulates cellular identity. 
  
Here, we have defined the nuclear organization signatures based on LB1 and H3K9me2 
occupancy via ChIP-seq across thirteen isogenic human cell types from all four germ 
layers derived from H9 embryonic stem cells. By linking these with transcriptional data, 
we identify evidence of cooperative shifts between chromatin structure and gene 
expression associated with each cell type. Overall, this work provides an atlas of 
peripheral chromatin and associated features in multiple human cell types across all 
four germ layers. 
 
5.2 A 3-state Hidden Markov Model approach identifies two categories of LADs 
that vary by cell type 
 
We generated ChIP-seq datasets for lamin-B1 from thirteen human ES-derived cell 
types comprising all four germ layers and representative of multiple early differentiation 
trajectories (Table 2). Visual inspection of these data confirmed the presence of large, 
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diffuse domains of enrichment of LB1 signal consistent with the presence of LADs in all 
cell types 
investigated. Due to the 
diffuse nature of these 
LB1-enriched domains 
and inspired in part by 
previous work (Meuleman et 
al., 2013), I implemented a 
Hidden Markov Model 
trained on the tier one cell 
types (Table 2) to identify 
LADs based on the LB1 
ChIP-seq input. A three-
state rather than the 
previously described two-
state model was better able 
to accurately identify LAD-
like domains, evidenced by 
their LB1 binding, genome ,  
region size and concordance with enriched domains evident by visual inspection. 
Among the three states, one state demonstrated the greatest enrichment for LB1 signal, 
and so was designated as LADs, with the remaining states were classified as LADlite 
and nonLAD by descending LB1 signal (Figure 24). LADs in each cell type 
Cell Type Germ Layer Tier 
H9-Derived Embryonic Stem Cells Embryonic 1 
Cardiac Myocytes Mesoderm 1 
Early Somite Mesoderm 1 
Paraxial Mesoderm Mesoderm 1 
Epicardium Mesoderm 2 
Day 4 Artery Mesoderm 2 
Sorted Cardiac Myocytes Mesoderm 2 
Mid-Hindgut Endoderm 1 
Liver Endoderm 1 
Endothelial Progenitors Endoderm 2 
Definitive Ectoderm Ectoderm 1 
Day 5 Midbrain Ectoderm 1 
Border Ectoderm Ectoderm 2 
Table 2: Cell types with LB1 and H3K9me2 ChIP-seq data 
LB1 and H3K9me2 ChIP-seq data were generated from each of 
the listed cell types. 
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demonstrated characteristic features, 
including enrichment for the repressive 
histone mark H3K9me2, lower gene 
density, generally lower gene expression, 
and less overlap with ATACseq peak 
compared to LADlites and nonLADs. 
Median LAD sizes for tier one cell types 
ranged from 160-280kb, covering 21.4%-
38.3% of the genome. We found that 
some genomic loci were classified as 
LADs in every cell type assessed, 
consistent with previously described 
constitutive LADs, while others varied by 
cell type, consistent with facultative LADs 
that vary between cell types (Meuleman et 
al., 2013; Peric-Hupkes et al., 2010). 
LADs and LADlites are generally more 
conserved, and tend to have lower GC 
content compared with nonLADs, and 
genomic loci that are categorized at LADs 
in all cell types are depleted for CpG 
islands. LADs and LADlites tend to have 
lower amounts of within-domain CTCF 
Figure 24: Properties of LADs 
LB1, H3K9me2, gene density, gene 
expression and ATACseq peak overlap in 
LAD categories in embryonic stem cells. 
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binding, while their boundaries show higher 
relative binding, particularly on the 5’ 
boundary. LADs are enriched for late-
replicating genomic regions, indicating that 
they are replicated later than nonLAD and 
LADlites during cell division. While in general 
LADs tend to be depleted for transposable 
elements, LADs and LADlites vary in their 
signal depending on the category of 
transposable element. For example, LADlite 
are depleted for LINE elements while LADs 
are enriched, and LADs are enriched for 
simple repeats while LADlites are depleted. 
These findings support the conclusion that 
our model was successfully able to identify 
and differentiate two distinct categories of 
lamin-associated genomic loci based on 
lamin-B1 ChIP-seq data. 
 
 
 
 Figure 25: Properties of KDDs 
H3K9me2, LB1, gene density, gene 
expression and ATACseq peak overlap in 
KDD categories in embryonic stem cells. 
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5.3 A 2-state Hidden Markov Model identifies H3K9me2 domains 
 
We generated ChIP-seq datasets for H3K9me2 from thirteen human ES-derived cell 
types comprising all four germ layers and representative of multiple early differentiation 
trajectories (Table 2). In order to distinguish H3K9me2 domains from LADs described 
above, I trained another HMM on the H3K9me2 ChIP-seq tier one data, in this case 
finding a two-state model to be the best fit to the data. From the two states identified by 
the model, the state with higher H3K9me2 signal was assigned the label of H3K9me2-
associated domain (K9-dimethyl domain, “KDD”), and the other state “nonKDD” (Figure 
25). KDDs in each cell type demonstrated enrichment for LB1, lower gene density, 
generally lower gene expression, and less overlap with ATACseq peaks compared to 
nonKDDs (Figure 25). Median KDD sizes for tier one cell types ranged from 380-
2360kb, covering 44.2%-82.8% of the genome. As found with LADs and LADlites, some 
genomic loci were classified as KDDs in all cell types assessed, while others varied per 
cell type. KDDs are depleted for CTCF, with a sharp increase in binding at their 
boundaries. Overall, these data confirm prior findings that H3K9me2-enriched regions 
share many characteristics with LADs (Kind et al., 2013).  
 
5.4 LADs and KDDs are overlapping but distinct 
 
We found that generally most LADs (>90% for 7 of 8 tier one cell types) are in KDDs, 
while generally about half of KDDs were in LADs. Exceptions, such as in the case of 
definitive ectoderm where only 10% of LADs are in KDDs, likely stem from the 
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additional noise present in the LB1 ChIP-seq data for that cell type, leading to instances 
where loci that are likely LADs were instead categorized as LADlite. Median region 
sizes for LADs that overlap KDDs range from 300-820kb, skewing larger in comparison 
to LADs and falling within the lower range of KDD sizes. Genomic loci categorized as 
both LADs and KDDs tend to have a higher LB1 ChIP-seq signal, while loci that are 
LADs but not KDDs have slightly higher LB1 signal compared to loci that are KDDs but 
not LADs. Genomic loci categorized as both LADs and KDDs also tend to higher 
H3K9me2 ChIP-seq signal, while loci that are KDDs but not LADs have slightly higher 
H3K9me2 signal compared to loci that are KDDs but not LADs. Genomic loci that are 
KDDs but not LADs seem to have higher boundary-associated CTCF signal. Taken 
together, these data may indicate that genomic loci categorized as both LAD and KDD 
constitute a particularly robust category of LAD with strong signals of genomic 
repression and association with the nuclear lamina. 
 
5.5 LADs, KDDs and A and B compartments 
 
LADs share many characteristics with B compartments, large swaths of 
heterochromatin with many of the same characteristics as LADs, such as low gene 
expression and low gene density. Therefore we assessed the concordance between 
LADs, LADlites and KDDs from cardiomyocytes and ESCs with the B compartment 
calculated from previously published Hi-C data matched cell types (Zhang et al., 2019). 
The Jaccard index, a measure of similarity, is greater for KDDs (Jaccard=0.62) than for 
LADs (Jaccard=0.55), indicating greater overlap with B compartments. However, the 
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Jaccard index for the concatenation of LADs and LADlites (Jaccard=0.75) is the largest, 
and greater even than the concatenation of LADs, LADlites and KDDs (Figure 26). The 
same trend was observed in ESCs. This validates the idea that lamina-associated 
chromatin occupies a similar fraction of chromatin as B compartments, consistent with 
the similar characteristics of both. However, the overlap of these different categories of 
chromatin is far from perfect, suggesting that while these domains are similar, they may 
be functionally distinct. 
 
5.6 Cell type specificity in LADs, LADlites and KDDs 
 
As previously noted, a subset of LADs, LADlites and KDDs vary between different cell 
types while the remainder are cell-type invariant. A caveat here is that it is likely that 
some of the regions identified as invariant by this analysis do actually vary in other cell 
Figure 26: B compartment overlap LADs and HADs 
Overlap with B compartment from Hi-C data for matched cell types for LADs 
overlapping HADs, and LADs and HADs alone.  
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types not tested in this study. Supporting this, we found immune-related transcription 
factor binding motifs in loci that are LADs in all cell types, indicating that potentially 
these loci detach from the lamina in immune cell types. However, some of the loci 
identified by this study are likely to actually be cell-type invariant. We found that LADs 
that overlap KDDs are significantly more likely to overlap a cell-type invariant LAD in 
most cell types (Fisher’s exact test p-value < 0.05). Therefore, the combination of LAD 
and KDD may represent a genomic region that is more stably linked to the nuclear 
lamina both within and between cell types.  
 
I investigated whether cell type variable loci contained cell-type-specific features. Gene 
ontology (GO) analysis on genes that fall in genomic loci that are LADs or LADlites in all 
cell types assayed resulted in processes that might be expected to be shared, such as 
chromosome segregation. Genomic loci that were categorized cell-type-specifically as 
LADs or LADlites tended to include more cell-type-relevant terms, such as embryo 
development and gastrulation for H9ESCs and regulation of neurogenesis for Day5-
Midbrain. 
 
I assessed differential enrichment transcription factor binding motifs (TFBMs) analysis 
across various sets to determine whether this would reflect cell-type-specific signals. 
Relative to the union of LADs from all cell types, cardiomyocyte LADs were enriched for 
motifs for genes involved in differentiation and processes of cell types other than 
cardiomyocytes, such as CDX2, implicated in the intestinal epithelium, NKX2.2, 
implicated in immune- and neuronal-related gene regulation, neuronal gene SOX6, 
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epithelial gene HOXB13, and insulin metabolism gene FOXO1. This supports the idea 
that non-cardiac genes are silenced and therefore located in LADs in cardiomyocytes. 
Some of the transcription factors listed are known to have a preference to bind 
methylated DNA and/or have repressive functionality, and therefore may contribute to 
the silencing of their target genes and potentially the generation of heterochromatin 
and/or sequestration to the nuclear lamina in those loci. Similarly, Day 5 Midbrain LADs 
relative to all LADs were enriched for TFBMs for non-neuronal genes, for example some 
relevant to heart including SOX17, NR2F2 and DLX2, and some involved in 
pluripotency, including OCT4 and SOX1. ESC LADs relative to all LADs were enriched 
for all of the transcription factors listed above for cardiomyocytes, as well as many 
additional related to differentiation and functionality in differentiated cell types, in line 
with the repression of these genes in pluripotent cells. Overall these findings are 
consistent with a model in which repression of expression of genes regulated by cell-
type-relevant transcription factors is accomplished through sequestration of TFBMs and 
transcription start sites in LADs of other cell types in order to protect cell identity and 
differentiation fidelity. 
 
I next sought to determine whether there was evidence for difference in enrichment of 
cell-type-relevant TFBMs in different LAD categories and KDDs, which may lend insight 
into the different functions of these domains. I found enrichment of TFBMs for many 
cardiac-defining transcription factors in LADlites compared to LADs in cardiomyocytes, 
including GATA2, PLAGL1, HAND2, and TBX5. Furthermore, we found enrichment of 
multiple pluripotency-maintenance genes in LADlites relative to LADs in 
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cardiomyocytes, including OCT4, SOX1, SOX2, SOX3, SOX15, KLF4, KLF1, MYC, and 
NANOG. The same trend was seen in H9ESCs. Overall, this supports the hypothesis 
that LADlites may represent a distinct chromatin region relative to LADs, important for 
cell type differentiation and maintenance. KDDs were enriched for multiple heart- and 
pluripotency-important genes relative to LADs in cardiomyocytes, which may reflect the 
overlap of KDDs with LADlites. It also may reflect the higher density of genes in KDDs 
relative to LADs. Overall it seems that LADlites and KDDs are more dynamic compared 
to LADs and important for cell type differentiation and maintenance. 
 
5.7 Discussion 
 
Maintenance of chromatin structure via association with the nuclear periphery is among 
the many factors contributing to successful cell type specification and identity (Poleshko 
et al., 2017). LADs have previously been shown to demonstrate heterogeneity among 
different cell types and even between single cells. In this work we have captured some 
of that heterogeneity using bulk measurements of LB1 and H3K9me2 DNA binding in 
various cell types, validating previous findings of LAD cell type specificity in a wide 
range of cell types and germ layers and further differentiating two distinct LAD 
categories within each cell type. The driving forces of these distinct LAD categories are 
as of yet unknown, but likely possibilities include the categories reflecting different 
frequencies of lamina-attachment between single cells as previously demonstrated 
(Kind et al., 2015). Furthermore, we were able to define an independent domain, the 
KDD, based on H3K9me2. Various characteristics of KDDs relative to LADs and 
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LADlites, such as gene expression, gene density, and ATACseq accessibility, support 
the idea that KDDs represent a specific kind of functional domain. Genomic loci that are 
both LADs and KDDs appear to represent the most stable peripheral heterochromatin 
both within and between cell types.  
 
Overall, this work takes domains that were previously viewed as a single monolithic 
entity, LADs, and characterizes a cell-type-specific set of overlapping but distinct 
domains. This follows the general trend of genomics, in which no locus can be simply 
defined, and most often has multiple functions depending on its context (Halfon, 2019). 
These findings lay the groundwork for future studies aimed at defining the driving cause 
behind the difference between LADlites and LADs – are these truly more dynamic 
regions, or do they vary cell-to-cell, leading to the distinct bulk LB1 measurements? Is 
the enrichment of cell-type-specific TFBMs in LADs, LADlites and KDDs a driving force 
in, or a consequence of, differentiation and cell identity? 
 
5.8 Methods 
 
Methods are provided here for the computational parts of this project only as that was 
my contribution to this work. 
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ChIP-sequencing data processing for Lamin-B1 and H3K9me2 
 
Adapters were trimmed using Trimmomatic [v0.39] (Bolger et al., 2014). Sequencing 
reads were aligned to human reference hg38 using BWA-MEM [v0.7.17] (Li and Durbin, 
2010). The FASTA file for hg38 was downloaded from the UCSC Genome Browser. 
Aligned reads were converted to BAM and sorted using Samtools [v0.1.19] (Heintzman 
et al., 2009), with quality filter (“-F”) set to 1804. Duplicates were removed using Picard 
[v2.18.7] MarkDuplicates. Sequencing reads from the ENCODE blacklist were removed 
using Bedtools [v2.29.0] (Quinlan and Hall, 2010). Each replicate had at least 1 million 
mapped sequencing reads. Data for both LB1 and H3K9me2 ChIP-seq were divided 
into higher quality (“tier one”) and lower quality (“tier two”) as assessed by replicate 
correlation values and visual assessment in order to generate stringent sets to train the 
LAD- and KDD-calling models (Table 2). Spearman correlations between biological 
replicates was greater than 0.7 for all tier one cell types, and greater than 0.6 for tier two 
cell types assessed by comparing bigwig files for SES-normalized signal over controls 
generated with bamCompare using multiBigWigSummary and plotCorrelation from 
deepTools [v3.3.2] (Ramírez et al., 2014). 
 
Identification of LADs 
 
LB1 ChIP-seq signal were calculated and converted into BedGraph files using 
deepTools bamCompare [v3.3.2] (Ramírez et al., 2014) with 20kb bins, using the signal 
extraction scaling method (Diaz et al., 2012) for sample scaling. A 3-state HMM was 
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implemented using pomegranate [v0.11.1] (Schreiber, 2017). The HMM was initialized 
using a normal distribution and k-means to initialize the distribution with a uniform 
transition matrix. The Baum-Welch algorithm was then used to train the model, with tier 
one cell types (Table 2) used together in the model training. The model was then 
applied to predict LAD state genome-wide per 20kb bins for each cell type from both tier 
one and tier two individually, filtering regions from the ENCODE blacklist from 
consideration. States were labeled as LAD, LADlite or nonLAD based on median LB1 
signal for the bins with that state label, with the highest median LB1 signal being 
assigned LAD, second highest LADlite, and lowest nonLAD. 
 
Identification of KDDs 
 
H3K9me2 ChIP-seq signal were calculated and converted into BedGraph files using 
deepTools bamCompare [v3.3.2] (Ramírez et al., 2014) with 20kb bins, using the signal 
extraction scaling method (Diaz et al., 2012) for sample scaling. A 2-state HMM was 
implemented using pomegranate [v0.11.1] (Schreiber, 2017). The HMM was initialized 
using a normal distribution and k-means to initialize the distribution with a uniform 
transition matrix. The Baum-Welch algorithm was then used to train the model, with tier 
one cell types (Table 1) used together in the model training. The model was then 
applied to predict KDD state genome-wide per 20kb bins for each cell type from both 
tier one and tier two individually, filtering regions from the ENCODE blacklist from 
consideration. States were labeled as KDD or nonKDD based on median H3K9me2 
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signal for the bins with that state label, with the highest median H3K9me2 signal being 
assigned KDD and lowest nonKDD. 
 
RNA-sequencing analysis 
 
Transcriptome data were quantified using Kallisto [v0.44.0] quant with fragment length 
determined by BioAnalyzer, standard deviation of 10, and 30 bootstraps, assigning 
reads using the Ensembl [v96] genome annotation (Bray et al., 2016). TPM values were 
quantile-normalized between cell types. Differentially expressed transcripts (q<=0.01) 
between cell types were identified using Sleuth [0.30.0] (Pimentel et al., 2017). RNA-
seq data for cardiomyocytes, embryonic stem cells and day-15 endothelial cells were 
generated in the Jain lab, early somite and paraxial mesoderm were from (Koh et al., 
2016), mid-hindgut from (Loh et al., 2014) and neural ectoderm from (Tchieu et al., 
2017). All RNA-seq data were reanalyzed as described above. 
 
Transcription factor binding motif analysis 
 
Differential transcription factor binding was analyzed using Homer [v4.11.1] (Heinz et 
al., 2010). 
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A and B compartment analysis 
 
Hi-C data for cardiomyocytes and embryonic stem cells were downloaded as Cooler 
files from the 4D Nucleome Data Portal (Zhang et al., 2019). A and B compartments 
were called using cooltools [v0.3.0] (Abdennur and Mirny, 2020). 
 
Supporting analyses 
 
Plotting, statistical analyses and supporting analyses were conducted in Python [v3.6] 
with packages Jupyter, matplotlib (Hunter, 2007), seaborn (Waskom et al., 2018), 
upsetplot (Lex et al., 2014), scikit-learn (Pedregosa et al., 2011), numpy (Walt et al., 
2011) and pybedtools (Dale et al., 2011; Quinlan and Hall, 2010). 
 
6 Conclusion 
 
The work I have presented here in this dissertation investigates and emphasizes the 
role of genomic variation, in multiple dimensions and timescales, in health, development 
and evolution. This work provides a tool to use sequence variation to design 
therapeutics for genomic disease, investigates the role of structural and sequence-
based genomic variation in evolution, uses sequence genomic variation across species 
to predict susceptibility to a viral pathogen and investigates the role of structural 
genomic variation in cell type specification. This work is a reflection of and contribution 
towards our growing understanding of the complexity of each aspect of our genomes. In 
 91 
chapter 2, I describe a software tool I built, AlleleAnalyzer, which incorporates genomic 
sequence variation into gRNA design. This tool enables allele-specific gRNA design, 
which may help to enable a cure for diseases driven by a single allele, such as 
dominant negative or imprinting diseases. AlleleAnalyzer also may enable experiments 
that depend on targeting a specific allele, or enable more accurate editing of a region 
with genetic variation relative to a reference genome. In chapter 3, I investigate how 
genomic variation makes us human, and how structural genomic variation may 
contribute to accelerated sequence evolution. By implementing the HAR discovery 
pipeline using Nextflow, it is now more reproducible and easier to change parameters, 
and ascertain the impact of various components of the pipeline. Via this process, I 
discovered that alignment and assembly quality are important for HAR discovery, and 
defined a new set of HARs. My finding that HARs are enriched in TADs with human-
specific structural variants suggests the possibility of enhancer hijacking as a driving 
factor in the accelerated evolution of HARs, a line of investigation which will need to be 
followed up by further analyses and experimental work. As I was writing this thesis, the 
world was upended by COVID-19, a disease caused by the virus SARS-CoV2. 
Therefore, I joined a team of scientists from all over the world, applying my skills in 
comparative genomics developed in work pertaining mainly to chapter 3 towards this 
virus. In chapter 4, I assess selection in a receptor known to mediate infectivity by 
SARS-CoV2 which contributed toward a method to predict risk of infection to other 
species. This will inform future risk predictions, potentially choice of model animals for 
therapeutic and vaccine development, and conservation efforts for endangered species. 
In chapter 5, I investigated how changes in genomic loci that are associated with 
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binding of LB1 or H3K9me2 impact cell type specificity. Through this work I discovered 
that LADs are not a single monolithic entity, but instead a set of distinct but overlapping 
domains. The differences between these domains appear to be related to cell type 
differentiation and maintenance, and may better inform how the 3D genome participates 
in and potentially influences cell type specification. Overall, my dissertation work 
improves our understanding of how genomic variation, in all its forms, is important to 
evolution, development, and disease. 
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